IP®EVIEW - Skadden
IP®EVIEW - Skadden
IP®EVIEW - Skadden
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Skadden</strong>, Arps, Slate, Meagher & Flom LLP<br />
and its affiliates provide this newsletter for<br />
educational and informational purposes only<br />
and it is not intended and should not be construed<br />
as legal advice. This newsletter is considered<br />
advertising under applicable state laws.<br />
IP® EVIEW<br />
Welcome to the <strong>Skadden</strong> IP Review<br />
Winter 2009<br />
Our latest edition includes two cover stories: a look at a recent Sixth Circuit ruling likely to affect IP license transfers in statutory<br />
mergers; and a follow-up report on how the U.S. Supreme Court’s potential adoption of the Federal Circuit’s “machine-or-transformation”<br />
test in its 2008 Bilski decision may impact the validity of patents and the claims of current applicants. We also cover topics<br />
such as the use of social media to promote FDA-regulated products and recent developments in FTC safe harbor enforcement, and<br />
discuss patents, trademarks, privacy and other issues.<br />
We welcome your comments and suggestions. A list of <strong>Skadden</strong>’s Intellectual Property and Technology contacts appears on page 18.<br />
Mergers and the Transfer of IP Licenses<br />
A recent ruling by the U.S. Court of Appeals for the Sixth Circuit<br />
prohibiting the transfer of an intellectual property license agreement<br />
in the context of what was, in effect, purely an internal corporate<br />
restructuring could have broad implications for many corporate transactions.<br />
In Cincom Systems Inc. v. Novelis Corp., 1 the court found<br />
that the defendant had violated the nontransferability provision of a<br />
license agreement because an entity other than the original licensee<br />
ended up holding the license (as a result of a statutory merger in<br />
which the original licensee was the nonsurviving entity). Although<br />
only binding in the Sixth Circuit, given the court’s broad ruling and the<br />
dearth of authority on the issue of transferring intellectual property<br />
licenses in statutory mergers, the case could have a broad impact.<br />
Background<br />
In 1989, Cincom Systems Inc. licensed Alcan Rolled Products Division<br />
the right to use certain Cincom software on a particular computer<br />
located in Oswego, N.Y. The license, which was governed<br />
by Ohio law, specified that it was not transferable by Alcan without<br />
Cincom’s prior written approval. 2 In 2003, Alcan’s parent corporation<br />
conducted a corporate reorganization pursuant to which Alcan<br />
was merged into a sister entity incorporated in Texas and Alcan<br />
( continued on page 2 )<br />
The Reign of Bilski: One Year After the<br />
Machine-or-Transformation Test<br />
On November 9, 2009, the U.S. Supreme Court heard oral<br />
argument on the proper test for patent-eligible subject matter<br />
under 35 U.S.C. § 101 and will subsequently determine, barring<br />
unforeseen circumstances, whether the Federal Circuit’s<br />
en banc decision in In re Bilski, 545 F.3d 943 (Fed. Cir. 2008),<br />
cert. granted, 129 S. Ct. 2735 (2009), applied the correct legal<br />
standard. Notwithstanding the pending review, a large number<br />
of decisions addressing patent eligibility have been rendered<br />
in the year since Bilski was decided. As highlighted below, the<br />
application of Bilski to issued patents and pending applications<br />
portends that Supreme Court adoption of the Federal Circuit’s<br />
“machine-or-transformation” test could significantly impact<br />
the scope of patent-eligible subject matter and the validity of<br />
patents that were issued prior to Bilski. Should the Supreme<br />
Court approve the Federal Circuit’s test, patent applicants will<br />
need to modify their pending claims accordingly, and patent<br />
owners will need to review their existing patent portfolios for<br />
compliance with the “machine-or-transformation” test (with the<br />
concomitant filing of reissue applications in order to modify the<br />
scope of claims that fail to pass the test).<br />
( continued on page 11 )<br />
Mergers and the Transfer of IP Licenses_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ p a g e 1<br />
The Reign of Bilski: One Year After the Machine-or-Transformation Test _ _ _ _ _ page 1<br />
FDA Conducts Public Hearing on the Use of the Internet and<br />
Social Media in the Promotion of FDA-Regulated Products _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 2<br />
Recent FTC Enforcement of Safe Harbor Has<br />
Broad Implications for Privacy Policies _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 3<br />
Federal Circuit Allows Hidden Unwitting Assignment by Employee<br />
Inventor to Defeat Standing to Sue for Patent Infringement _____________ page 5<br />
First Sale Doctrine Under Attack _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 6<br />
Federal Circuit Issues Two Key Decisions<br />
Clarifying Rights of Patent Licensees _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 8<br />
ISPs Immunity From Contributory Infringement Not Absolute _ _ _ _ _ _ _ _ _ _ _ _ page 9<br />
SEC Imposes $100,000 Fine for Firm’s Failure<br />
to Safeguard Customer Information ____________________________page 10<br />
<strong>Skadden</strong> Contacts _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _page 18
( continued from page 1 )<br />
Mergers and the Transfer of IP Licenses<br />
ceased to exist. After further corporate restructuring and multiple<br />
name changes, 3 Novelis Corp. emerged as the holder of the Cincom<br />
license. Nonetheless, the Cincom software continued to be used by<br />
the same business unit that was using it since 1989 and on the same<br />
designated computer in Oswego, N.Y. Novelis did not seek or obtain<br />
Cincom’s written consent to any portion of the reorganization. 4<br />
Cincom filed suit, alleging that the transfer of the license to Novelis<br />
violated that agreement’s anti-assignment clause, and that Novelis<br />
was infringing Cincom’s copyright by using the software.<br />
The Sixth Circuit’s Opinion<br />
The Sixth Circuit began by citing the fundamental principle that, under<br />
federal law, intellectual property licenses cannot be assigned without<br />
express consent. According to the court, without such a prohibition,<br />
a licensor would effectively lose control of its intellectual property<br />
asset. Therefore, while state law can govern the interpretation of an<br />
intellectual property license, it cannot be used to reverse the federal<br />
prohibition against the unauthorized transfer of intellectual property<br />
licenses. According to the court, since Ohio merger law operated to<br />
transfer the license from Alcan to Novelis, Novelis had breached the<br />
nontransferability provision of the license and was using Cincom’s<br />
copyrighted software without permission.<br />
The court cited its 1979 decision in PPG Industries, Inc. v. Guardian<br />
Industries Corp. 5 to support its holding. In that case, PPG had<br />
granted Permaglass a nontransferable patent license. Permaglass<br />
then merged into Guardian, a competitor of PPG. Under Delaware<br />
and Ohio law, which governed that merger, Permaglass’ licenses<br />
automatically transferred to Guardian. The Sixth Circuit held, however,<br />
that state law could not override the presumption that intellectual<br />
property licenses were nonassignable without express consent, and<br />
therefore Guardian was in breach of the license. 6<br />
Novelis attempted to distinguish PPG on the grounds that the surviving<br />
entity in that case was a competitor of the licensor. The court<br />
acknowledged that the primary purpose of the federal law prohibiting<br />
unauthorized transfers was to prevent a license from falling into the<br />
hands of a competitor. However, the court stressed that this federal<br />
law applies in all circumstances, not just those in which there is a<br />
transfer to a competitor.<br />
Novelis next argued that the court should reconsider its holding in PPG<br />
given that the Ohio merger statute had been modified since 1979 and<br />
now appeared to clarify that a merger did not effectuate a transfer of<br />
all agreements. Specifically, when PPG was decided, Ohio’s merger<br />
law stated that all assets of the nonsurviving party in a merger were<br />
“deemed to be [t]ransferred to and vested in” the survivor. 7 Ohio subsequently<br />
adopted a new merger statute which states that all assets<br />
of the nonsurviving party to a merger are “vested in” the survivor. 8<br />
Novelis argued that the deletion of the word “transferred” from the<br />
statute indicates that a merger under Ohio law is no longer a transfer.<br />
Therefore, when Novelis became the licensee under the Cincom<br />
license, it was not because a “transfer” had taken place. 9<br />
The court rejected this argument, noting that the vesting of a license<br />
in a new entity could only occur if it was transferred from the old<br />
entity. More importantly, the court stated broadly that “in the context<br />
of a patent or copyright license, a transfer occurs any time an entity<br />
other than the one to which the license was expressly granted gains<br />
possession of the license” (emphasis in original). 10 Moreover, the<br />
IP® EVIEW<br />
2<br />
court indicated that even if the license is silent as to transferability, the<br />
federal rule would prohibit transfer without consent.<br />
Practical Implications<br />
Although Cincom is binding only on courts in the Sixth Circuit, given<br />
the dearth of case law in this area, licensors seeking to challenge a<br />
transfer will likely urge courts in other circuits to follow the logic of<br />
the Cincom court. This case could therefore be the basis of a new<br />
de facto standard in which licensor consent is required even in the<br />
context of statutory mergers. This could increase transaction costs<br />
(if the licensor seeks compensation for its consent) and could delay a<br />
signing or closing (while consents are obtained).<br />
Ultimately, the greatest challenge for licensors and licensees may<br />
be determining the full reach of the Cincom decision. Read literally,<br />
the court’s somewhat ambiguous holding — that a transfer of an<br />
IP license has occurred any time a new entity “gains possession”<br />
of the original licensee — easily could encompass sales of stock<br />
and other corporate transactions that generally are not thought of<br />
as requiring consent from IP licensors. Although it seems unlikely<br />
that the court intended such a result, it is difficult to discern a clear<br />
boundary from its reasoning or holding. Until such time (if any) that<br />
Cincom is further clarified, parties should carefully analyze proposed<br />
corporate transactions in light of their existing IP licenses and the<br />
holding in Cincom.<br />
Finally, Cincom turned on the fact that the license included a broad<br />
prohibition against transfer. When negotiating license agreements<br />
going forward, licensees should be sure to seek the right to transfer<br />
the license without consent in the context of a merger or other<br />
change of control events. �<br />
1 2009 U.S. App. LEXIS 21172 (6 th Cir.).<br />
2 Id. at *2.<br />
3 The Sixth Circuit is somewhat unclear about the specifics of these other steps,<br />
stating that the Texas entity merged into itself and three of its subsidiaries. Id. at *4.<br />
However, there were stipulated facts filed with the district court that described the<br />
corporate restructuring efforts. In effect, the licensee was merged out of existence.<br />
4 Id. at *3.<br />
5 597 F.2d 1090 (6 th Cir. 1979).<br />
6 The license agreement at issue in PPG was terminable by the licensor if the licensee<br />
became controlled by a competitor of the licensor.<br />
7 Ohio Rev. Code Ann. § 1701.81(A)(4)(1955).<br />
8 Ohio Rev. Code Ann. § 1701.82(A)(3)(2009).<br />
9 Cincom at *15.<br />
10 Cincom at *16 – *17.<br />
FDA Conducts Public Hearing on the Use of<br />
the Internet and Social Media in the Promotion<br />
of FDA-Regulated Products<br />
On November 12 and 13, 2009, the United States Food and Drug<br />
Administration (FDA) held a public hearing and request for comments<br />
to discuss issues related to the promotion of FDA-regulated<br />
products (e.g., prescription drugs, prescription biologics and medical<br />
devices) using the Internet and social media tools. 1 Comments will<br />
be accepted until February 28, 2010.<br />
( continued on page 3 )
( continued from page 2 )<br />
Background<br />
In the official notice announcing the hearing, the FDA recognized that<br />
the Internet has become a widely used medium for FDA-regulated<br />
companies (e.g., manufacturers, packers and distributors of regulated<br />
products) to disseminate information about their products. The FDA<br />
also acknowledged that the second generation of Web development<br />
and Web design (Web 2.0) has led to the emergence of a variety of<br />
social networking tools (e.g., blogs, podcasts, social network sites,<br />
video sharing, widgets and wikis) that have raised questions and concerns<br />
over how to apply existing FDA regulations to these newer media.<br />
As a result, the FDA has been evaluating the extent to which existing<br />
laws, regulations and policies concerning advertising and promotional<br />
labeling of regulated products should be applied on the Internet.<br />
To date, however, the FDA has not issued specific regulations or<br />
guidance on Internet promotions, despite the industry’s continued<br />
request for such guidance. Instead, the FDA has continued to<br />
apply its “print-based” media rules to online promotion, essentially<br />
ignoring the special characteristics of Web 2.0 and other<br />
emerging technologies.<br />
Past FDA Enforcement Activity Relating to Online Promotion<br />
Sponsored Links<br />
In April 2009, the FDA issued Untitled Letters 2 to 14 pharmaceutical<br />
companies for violations relating to sponsored links on search<br />
engines. 3 Sponsored links are links or ads that are purchased to<br />
appear when a certain search term is entered. In this case, companies<br />
paid for their links to appear when searches were run for either<br />
the brand names of drug products or disease conditions. In each<br />
Untitled Letter, the FDA generally cited violations of the Food, Drug<br />
and Cosmetic Act (FDCA).<br />
Specifically, the FDA asserted that the sponsored links misbrand<br />
the drugs because they include representations and/or suggestions<br />
about their efficacy without communicating any risk information.<br />
Furthermore, the FDA stated that providing a link to the product’s<br />
Web site, where consumers could get more information about drug<br />
risks, did not mitigate the misleading omission of risk information.<br />
The Untitled Letters also claimed that the sponsored links failed adequately<br />
to communicate the drugs’ indication (i.e., what the drugs are<br />
used for) or, in some instances, broadened the indication by failing<br />
to disclose limitations to the indication, such as the appropriate<br />
patient population or disease stage. Finally, the FDA asserted that<br />
the sponsored links do not provide the drugs’ full established names<br />
in accordance with FDA regulations. In other words, the sponsored<br />
links refer only to the drugs’ proprietary names without also providing<br />
their established names (also known as “generic names”).<br />
YouTube Videos and Banner Ads<br />
Although the majority of the FDA’s online enforcement activities<br />
have focused on companies’ practices on official product Web<br />
sites, the FDA has also issued Warning Letters addressing the use<br />
of videos posted on third-party Web sites, and Untitled Letters<br />
addressing the use of “online banners.”<br />
For example, in August 2008, the FDA sent an Untitled Letter to<br />
Novartis Pharmaceuticals, objecting to the company’s use of online<br />
banners promoting Diovan. The FDA claimed that the banner ads<br />
presented efficacy claims but failed to communicate required risk<br />
information, thereby misbranding the drug.<br />
IP® EVIEW<br />
3<br />
Issues for Discussion<br />
According to the notice, the FDA is interested in comments on any<br />
aspect of Internet promotion in general. However, the FDA identified<br />
the following five categories for discussion at the November public<br />
hearing, based in large part on the specific types of issues frequently<br />
raised by interested parties.<br />
• For what online communications are manufacturers, packers or<br />
distributors of regulated products accountable?<br />
• How can manufacturers, packers or distributors fulfill regulatory<br />
requirements in their Internet and social media promotion?<br />
• What parameters should apply to the posting of corrective information<br />
on Web sites controlled by third parties?<br />
• When is the use of links appropriate?<br />
• Questions specific to Internet-adverse event reporting, including:<br />
How are entities with reporting responsibilities using the Internet<br />
and social media tools with regard to monitoring adverse event<br />
information about their products?<br />
With the emergence of new Web 2.0 technologies, the regulation<br />
of Internet and social media promotions will continue to present<br />
considerable challenges for the FDA and the industry as a whole.<br />
Therefore, it is important that all interested parties review the public<br />
notice and consider sending comments in order to assist the FDA in<br />
developing practical rules and regulations to accommodate a wide<br />
range of online promotional tools. �<br />
1 The Notice of Public Hearing: http://edocket.access.gpo.gov/2009/pdf/E9-22618.pdf.<br />
2 Untitled Letters “cite[] violations that do not meet the threshold or regulatory<br />
significance for a Warning Letter.” See FDA, Regulatory Procedures Manual at 4-2-1<br />
(Mar. 2009). Such violations “may lead to enforcement action if not promptly and<br />
adequately corrected.” Id at 4-1-1.<br />
3 The 14 Untitled Letters can be viewed on the FDA’s Web site: http://www.fda.gov/<br />
Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/<br />
WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/<br />
ucm055773.htm.<br />
Recent FTC Enforcement of Safe Harbor Has<br />
Broad Implications for Privacy Policies<br />
On October 6, 2009, the Federal Trade Commission (FTC) announced<br />
that it had settled charges brought against six different companies for<br />
misrepresenting that they were in compliance with the U.S.-European<br />
Union (EU) Safe Harbor framework (Safe Harbor). 1 These settlements<br />
mark the second time within the last two months that the FTC has<br />
settled a claim relating to the Safe Harbor, and may signal new scrutiny<br />
by the FTC into Safe Harbor compliance — an area that the FTC<br />
has not addressed since the framework was put in place 10 years ago.<br />
The FTC’s actions also serve as an important reminder that companies<br />
must be in compliance with all aspects of their stated privacy policies,<br />
whether or not they certify to the Safe Harbor.<br />
Safe Harbor Overview<br />
The EU Directive on Data Protection, 2 which went into effect in<br />
1998, generally prohibits the transfer of personal data to non-EU<br />
nations that do not meet the EU standard of “adequate” privacy protection.<br />
This presented a potential impediment for data transfers to<br />
( continued on page 4 )
( continued from page 3 )<br />
the U.S. given the U.S. reliance on industry self-regulation to protect<br />
many types of personal data. While companies may use so-called<br />
“model contracts” (i.e., written agreements that specify the means<br />
by which data will be protected), the U.S. Department of Commerce<br />
sought to create a streamlined method by which U.S. companies could<br />
meet the “adequacy” requirement of the directive.<br />
The Department of Commerce and the European Commission therefore<br />
negotiated a Safe Harbor framework which became effective<br />
in 2000. 3 By certifying to the Safe Harbor, a company establishes<br />
that it provides “adequate” data privacy protection as required under<br />
the EU Directive, and may therefore lawfully transfer personal data<br />
from the EU. In order to participate, companies must self-certify to<br />
the Department of Commerce that they comply with seven specified<br />
privacy principles — notice, choice, transfer to third parties,<br />
security, access, data integrity and enforcement. Most importantly<br />
for purposes of the recent FTC actions, participating companies<br />
must state in their published privacy policies that they adhere to the<br />
Safe Harbor, and must recertify each year if they choose to continue<br />
relying on this framework for EU-U.S. data transfers. Companies<br />
that fail to recertify are listed as “not current” on the Department of<br />
Commerce Web site.<br />
The FTC Enforcement Actions<br />
At various points between 2001 and 2007, the six settling companies<br />
had self-certified under the Safe Harbor. As required, each company<br />
also included a statement in its Web site privacy policy that it was<br />
participating in the Safe Harbor program and was adhering to the<br />
Safe Harbor Privacy Principles. 4 Several of the companies recertified<br />
at least once before ceasing to do so, while the remaining<br />
companies never recertified. In all instances, the Department of<br />
Commerce moved each company to its “not current” list, indicating<br />
that the companies had failed to recertify.<br />
Despite the fact that the companies had not recertified, each of them<br />
continued to include a statement in their privacy policy that they<br />
were Safe Harbor compliant. This erroneous statement remained<br />
on each company’s Web site for periods ranging from approximately<br />
six months to five years before the FTC brought its actions in the<br />
summer of 2009. In each case, the FTC alleged that because of the<br />
misleading statement regarding Safe Harbor compliance, each company<br />
had committed unfair or deceptive acts or practices in violation of<br />
Section 5(a) of the Federal Trade Commission Act.<br />
On October 6, 2009, the FTC announced its settlement with all six<br />
companies and issued proposed consent orders. 5 Pursuant to the<br />
consent orders, each company agrees not to “misrepresent in any<br />
manner, expressly or by implication, the extent to which [it] is a<br />
member of, adheres to, complies with, is certified by, is endorsed by,<br />
or otherwise participates in any privacy, security, or other compliance<br />
program sponsored by the government or any other third party.” 6<br />
For a period of five years, the companies must also maintain, and<br />
make available to the FTC, copies of all documentation related to<br />
compliance with the order, including advertisements, promotional<br />
materials and other statements containing representations covered<br />
by the orders.<br />
Implications of the FTC’s Actions<br />
Notably, the six settlements mark the second time within the last<br />
two months that the FTC has brought charges against a company for<br />
misrepresenting its Safe Harbor status. In August 2009, the FTC<br />
IP® EVIEW<br />
4<br />
obtained a temporary restraining order against a company for a number<br />
of allegedly deceptive acts or practices, including falsely representing<br />
that it self-certified to Safe Harbor when in fact the company had<br />
never participated in the program. 7 These recent actions suggest<br />
that the FTC may be responding to long-standing suggestions by the<br />
EU that the FTC needs to be proactive in monitoring whether organizations’<br />
privacy policies conform to the Safe Harbor. 8 Regardless of<br />
the FTC’s motivation, its recent focus in this area serves as an important<br />
reminder to companies that they must continue to re-certify<br />
their Safe Harbor compliance, or modify their privacy policies if they<br />
have chosen not to recertify or neglected to do so.<br />
These recent Safe Harbor cases are also consistent with recent<br />
efforts by the FTC to ensure that privacy policies are clear and match<br />
a company’s actual activities. Earlier this year, the FTC settled<br />
charges against an online retailer whose systems were hacked,<br />
exposing its customers’ data. The FTC claimed that the company’s<br />
privacy policy inaccurately described the strength of its information<br />
security policies. 9 Similarly, in its revised principles governing the<br />
use of personal data for online behavioral advertising, the FTC<br />
expressed its discontent with the “opaque privacy policies that only<br />
a lawyer can understand.” 10<br />
Practice Points<br />
• Companies that have self-certified to the Safe Harbor must<br />
keep in mind that they are required to self-certify each year if<br />
they want to remain under the protection of this framework<br />
to transfer personally identifiable data from the EU to the U.S.<br />
Companies should establish internal “reminders” so that they<br />
can begin the recertification process sufficiently in advance of<br />
when it is due.<br />
• Companies that have decided not to self-certify, or realize they<br />
have neglected to do so, must immediately modify their privacy<br />
polices to reflect that fact.<br />
• Even if a company is not certified under the Safe Harbor, it is<br />
critical for it to self-certify to ensure that its privacy policy accurately<br />
captures the company’s activities. Any inaccuracy can lead<br />
to a claim of unfair and deceptive misleading practices by the FTC.<br />
While an inaccurate privacy policy might seem like a minor issue,<br />
note that the implications can be significant if the FTC brings<br />
actions. In the six recently settled cases, the companies are<br />
prohibited from misrepresenting, expressly or by implication, their<br />
adherence to any compliance program, whether sponsored by the<br />
government or any other third party. �<br />
1 See Press Release, Fed. Trade Comm’n, FTC Settles with Six Companies Claiming to<br />
Comply with International Privacy Framework (Oct. 6, 2009), available at http://www.<br />
ftc.gov/opa/2009/10/safeharbor.shtm.<br />
2 Council Directive 95/46/EC, 1995 O.J. (L 281) 31 (EC).<br />
3 Participation is available only to those companies coming under the jurisdiction of the<br />
FTC or the U.S. Department of Transportation.<br />
4 See, e.g., Complaint at 3, In the matter of Progressive Gaitways LLC, No. 092-3141<br />
(Fed. Trade Comm’n 2009).<br />
5 The proposed consent orders are subject to public comment through November 5,<br />
2009, at which point the FTC will determine whether to finalize the orders.<br />
6 See, e.g., Agreement Containing Consent Order, In the Matter of World Innovators,<br />
Inc., No. 092-3137 (Fed. Trade Comm’n Oct. 6, 2009).<br />
7 Press Release, Fed. Trade Comm’n, Court Halts U.S. Internet Seller Deceptively<br />
Posing as U.K. Home Electronics Site (Aug. 6, 2009), available at http://www.ftc.gov/<br />
opa/2009/08/bestpriced.shtm.<br />
( continued on page 5 )
( continued from page 4 )<br />
8 See, e.g., Commission Staff Working Document on the Implementation of<br />
Commission Decision 520/2000/EC on the Adequate Protection of Personal Data<br />
Provided by the Safe Harbor Privacy Principles and Related Frequently Asked<br />
Questions Issued by the US Department of Commerce (Oct. 2004), available at<br />
http://ec.europa.eu/justice _home/fsj/privacy/docs/adequacy/sec-2004-1323 _en.pdf.<br />
9 See Press Release, Fed. Trade Comm’n, Identity Theft, Consumer Electronics<br />
Company Agrees to Settle Data Security Charges; Breach Compromised Data of<br />
Hundreds of Consumers (Feb. 5, 2009), available at http://www.ftc.gov/opa/2009/02/<br />
compgeeks.shtm.<br />
10 Fed. Trade Comm’n, Self-Regulatory Principles for Online Behavioral Advertising:<br />
Behavioral Advertising Tracking, Targeting, & Technology (2009), available at http://<br />
www.ftc.gov/os/2009/02/P085400behavadreport.pdf.<br />
Federal Circuit Allows Hidden Unwitting<br />
Assignment by Employee Inventor to Defeat<br />
Standing to Sue for Patent Infringement<br />
A recent decision by the U.S. Court of Appeals for the Federal Circuit<br />
in Board of Trustees of The Leland Stanford Junior University, et al., v.<br />
Roche Molecular Systems, Inc. et al. underscores the need to draft<br />
employee intellectual property assignment agreements with care<br />
and to consider carefully how to structure arrangements that permit<br />
employees to work as consultants to partners or third parties.<br />
Background<br />
The patents-in-suit claim methods for quantifying Human<br />
Immunodeficiency Virus (HIV) in human blood samples, and correlating<br />
those measurements to the therapeutic effectiveness of<br />
antiretroviral drugs. Three Stanford researchers — Mark Holodniy,<br />
Thomas Merigan and David Katzenstein — are named inventors<br />
on all of the patents; a fourth inventor, Michael Kozal, appears on<br />
one of the patents. The technology related to the patents-in-suit<br />
was developed in the late 1980s and early 1990s by researchers at<br />
Stanford and Cetus, a company where polymerase chain reaction<br />
(PCR) techniques matured in the early 1980s.<br />
In 1988, Holodniy joined Merigan’s laboratory at Stanford and<br />
signed a “Copyright and Patent Agreement” (CPA) that obligated<br />
him to assign his inventions to the university. In the CPA, Holodniy<br />
acknowledged that Stanford enters into “Contracts or Grants” with<br />
third parties, such as the government, and that he may “conceive<br />
or first actually reduce to practice” various inventions. Paragraph<br />
2 of the CPA then recites: “I agree to assign or confirm in writing<br />
to Stanford and/or Sponsors that right, title and interest in … such<br />
inventions as required by Contracts or Grants.”<br />
In February 1989, Holodniy began regular visits to Cetus over<br />
several months to learn PCR and to develop a PCR-based assay for<br />
HIV. Holodniy signed a “Visitor’s Confidentiality Agreement” (VCA)<br />
with Cetus. The VCA stated that Holodniy “will assign and do[es]<br />
hereby assign to CETUS, my right, title, and interest in each of the<br />
ideas, inventions and improvements” that Holodniy may devise “as<br />
a consequence of” his work at Cetus. Stanford was unaware of<br />
the VCA entered into by Holodniy, and no recordation of it was ever<br />
made in relation to any patent. Eventually, Holodniy’s research with<br />
Cetus produced an assay that used PCR to measure quantitatively<br />
the amount of plasma HIV RNA in samples from infected humans.<br />
Results obtained by the Stanford team using the new assay formed<br />
the basis for the patents-in-suit. Stanford and Cetus were also<br />
parties to various material transfer and other agreements related to<br />
this work.<br />
IP® EVIEW<br />
5<br />
In December 1991, Roche purchased Cetus’s PCR business, including<br />
its agreements with Stanford and its researchers. After this transaction,<br />
Roche began manufacturing HIV detection kits employing RNA<br />
assays. In May 1992, Stanford filed the patent application to which<br />
the patents-in-suit claim priority. The ’730 patent issued on October<br />
19, 1999; the ’705 patent issued on January 7, 2003; and the ’041<br />
patent issued on October 31, 2006, after this lawsuit began. Stanford<br />
is the named assignee of all three patents.<br />
Stanford received government funding for its HIV research through<br />
the National Institutes of Health (NIH). On June 24, 1992, Stanford<br />
filed an invention disclosure for the HIV RNA assay with the NIH. On<br />
November 29, 1994, Stanford confirmed to the government the grant<br />
of a “nonexclusive, nontransferable, irrevocable, paid-up license”<br />
under the parent application. On April 6, 1995, Stanford formally<br />
notified the government that it elected to retain title to the inventions<br />
under the Bayh-Dole Act, 35 U.S.C. §§ 200-212.<br />
Following failed discussions regarding licensing the patents, Stanford<br />
filed suit against Roche in the Northern District of California on<br />
October 14, 2005, alleging that Roche’s HIV detection kits infringe<br />
its patents. Roche answered and counterclaimed against Stanford,<br />
Merigan and Holodniy, asserting, inter alia, that Stanford lacked<br />
standing to maintain the cause of action against Roche, that Roche<br />
possesses ownership, license and/or shop rights to the patents<br />
through Roche’s acquisition of Cetus’s PCR assets, and that the<br />
asserted patent claims were invalid.<br />
The parties cross-moved for summary judgment on Roche’s rights<br />
in the patents, and the district court ruled that Roche’s pleading<br />
was a counterclaim subject to the applicable statute of limitations<br />
and not an affirmative defense, and ruled in Stanford’s favor on the<br />
ownership and standing issues finding that (1) Roche’s ownership<br />
claims were barred by California statutes of limitation, laches and the<br />
Bayh-Dole Act; (2) Roche’s license claims failed because Stanford<br />
never consented to Roche’s acquisition of Cetus’s patent licenses;<br />
and (3) Roche lacked shop rights to the patents.<br />
After briefing and a Markman hearing, the district court then<br />
construed several claim terms. Roche then moved for summary<br />
judgment that the asserted claims were invalid. The district court<br />
granted the motion, holding all asserted claims obvious.<br />
Stanford appealed the judgment of invalidity, and Roche crossappealed<br />
the judgment as to the parties’ respective rights in the<br />
patents.<br />
The Federal Circuit’s Decision<br />
On appeal, the Federal Circuit affirmed the district court’s dismissal<br />
of Roche’s ownership counterclaim, vacated the judgment that the<br />
asserted patent claims were invalid for obviousness, and remanded<br />
with instructions to dismiss Stanford’s claim because, despite its<br />
agreement with Holodniy and no actual notice of an assignment to<br />
Cetus, Stanford cannot establish ownership of Holodniy’s interest<br />
and therefore lacks standing to assert its claims of infringement<br />
against Roche.<br />
Present Versus Future Agreements to Assign<br />
A threshold issue in the case was which of the various agreements<br />
involving Holodniy (the CPA, the VCA or the recorded assignment<br />
to Stanford) was effective to transfer his interest in the invention.<br />
The Federal Circuit looked at the language in the CPA and VCA and<br />
( continued on page 6 )
( continued from page 5 )<br />
held that when he “agree[d] to assign” in the CPA, Holodniy merely<br />
promised to assign rights in the future to Stanford, while the VCA’s<br />
language of “do hereby assign” effected a present assignment of<br />
Holodniy’s future inventions to Cetus. Therefore, Cetus immediately<br />
gained equitable title to Holodniy’s inventions and once the invention<br />
was made and an application for patent was filed, Cetus’s equitable<br />
title converted to legal title. Although Holodniy executed an assignment<br />
of his rights in the parent application to Stanford, because Cetus’s legal<br />
title vested first, Holodniy no longer retained any rights, negating his<br />
subsequent assignment to Stanford during patent prosecution.<br />
Because it was undisputed that Holodniy took certain information<br />
and material from Cetus and used them to develop the PCR assay<br />
for HIV RNA. The Federal Circuit agreed with the district court<br />
that he developed the inventions “as a consequence” of his access<br />
to Cetus. Even if Holodniy conceived and reduced to practice after<br />
departing Cetus, his research was directly related to the collaboration<br />
with Cetus. Thus, the chain of title to Holodniy’s rights leads to Roche,<br />
leaving Stanford with defective title to the rights of all the inventors.<br />
Bona Fide Purchaser Under 35 U.S.C § 261<br />
Stanford asserted that it was a bona fide purchaser for value of<br />
Holodniy’s interest in the patents by virtue of the CPA and that Cetus’s<br />
failure to timely record the VCA gave Stanford superior title to that of<br />
Roche under 35 U.S.C. § 261. The Federal Circuit disagreed.<br />
In disagreeing with Stanford, the Federal Circuit first observed that<br />
the bona fide purchaser defense to patent infringement, while a<br />
matter of federal law, draws upon common law principles. On the<br />
basis of common law principles and dicta from one of its previous<br />
cases, 1 the court concluded that notice under Section 261 can<br />
include constructive or inquiry notice, in addition to actual notice, and<br />
that Stanford should be charged with notice of Holodniy’s assignment<br />
to Cetus on the basis that (1) the CPA established an employment<br />
relationship between Holodniy and Stanford, and Holodniy’s<br />
work at Cetus related directly to his research at the university; (2)<br />
Merigan, Holodniy’s supervisor at Stanford, directed Holodniy to<br />
work with Cetus and himself executed Materials Transfer Agreements<br />
with Cetus that allocated intellectual property rights; and<br />
(3) constructive notice applies under California law in particular to<br />
employees who are acting as agents of their employer. The Federal<br />
Circuit also found that Holodniy’s promise in signing the CPA to “not<br />
enter into any agreement creating copyright or patent obligations in<br />
conflict with this agreement” does not prevent imputation of notice<br />
to Stanford.<br />
Bayh-Dole Considerations<br />
Stanford contended that the Bayh-Dole Act allowed Stanford a “right<br />
of second refusal” to the patents after the government refrained<br />
from exercising its rights, that Holodniy’s rights were contingent<br />
upon his CPA obligations to assign them to Stanford, and that the act<br />
voided any assignment by Holodniy to Cetus upon Stanford electing<br />
title to the invention. The Federal Circuit disagreed, relying on its<br />
previous holding, that, 2 when the Bayh-Dole Act’s provisions are<br />
violated, the government can choose to take action and title to the<br />
patent may be voidable, but the Federal Circuit declined to expand<br />
that holding to find that title is automatically void. Instead, the<br />
Federal Circuit held that Holodniy’s assignment to Cetus provided<br />
the government with, at most, a discretionary option to his rights,<br />
but that absent exercise of that option, title remained with Holodniy<br />
or his assignee (Cetus).<br />
IP® EVIEW<br />
6<br />
The court went on to note that, at the time it elected title, Stanford<br />
was entitled to claim whatever rights were still available after the<br />
government declined to exercise its option, including the rights of coinventors<br />
Merigan, Katzenstein and Kozal. Holodniy, however, had<br />
transferred his rights to Cetus more than six years before Stanford<br />
formally notified the government of its election of title. The court<br />
specifically declined to express an opinion as to whether Holodniy’s<br />
execution of the VCA violated any provisions of the Bayh-Dole Act,<br />
or whether the act provides the government or Stanford some other<br />
legal recourse to recover Holodniy’s rights.<br />
Ownership and Standing<br />
While the court held Stanford is not able to establish clear title<br />
through all the inventors, it also upheld the district court’s dismissal<br />
of Roche’s ownership claims as time-barred under California’s applicable<br />
statute of limitations. Thus Roche was not awarded a judgment<br />
of ownership. Nonetheless, the court found that Stanford’s<br />
inability to establish that it possessed Holodniy’s interest in the<br />
patents-in-suit defeats its right to assert its cause of action against<br />
Roche, as it is well settled that “all co-owners normally must join<br />
as plaintiffs in an infringement suit. Thus, the Federal Circuit found<br />
that the district court lacked jurisdiction over Stanford’s infringement<br />
claim and should not have addressed the validity of the patents. �<br />
1 FilmTec Corp. v. Allied-Signal, Inc., 939 F.2d 1568, 1574 (Fed. Cir. 1991).<br />
2 Central Admixture Pharmacy Services, Inc. v. Advanced Cardiac Solutions, P.C. 482<br />
F.3d 1347, 1352-53 (Fed. Cir. 2007).<br />
First Sale Doctrine Under Attack<br />
A long-standing skirmish between brand owners and retailers over<br />
the right of unauthorized retailers to sell authorized goods recently<br />
has taken a pivotal turn. In a recent decision, Zino Davidoff SA v.<br />
CVS Corp, 1 the U.S. Court of Appeals for the Second Circuit held<br />
that the removal by a retailer of a Unique Production Code (UPC) on<br />
the plaintiff’s fragrance packaging violated the plaintiff’s trademark<br />
rights. As such, at least in the Second Circuit, a retailer that is not<br />
authorized to sell a branded product now may face the difficult<br />
dilemma of removing the UPC and risk engaging in trademark<br />
infringement or keep the UPC on the product packaging and facilitate<br />
the brand owner’s discovery (and termination) of the source of the<br />
diverted goods. In either event, the unauthorized resale of branded<br />
goods as we have come to know it may permanently be altered.<br />
Background<br />
For years, retailers have sold with relative impunity branded goods<br />
that were not intended by the brand owner to be sold through that<br />
retailer. We all have seen such sales, whether personal fragrances,<br />
designer apparel, luxury goods, fine chocolate or other high-end (and<br />
authentic) branded products being sold at a discount by a discount<br />
retail chain. Frequently such goods are sold directly to the discount<br />
retail chain by the brand owner’s exclusive distributors or by the<br />
unauthorized high-end retailer itself, seeking to sell excess inventory<br />
that the distributor or high-end retailer may not be able to sell<br />
through authorized channels.<br />
Brand owners have had a number of concerns regarding such resale,<br />
including that such unauthorized channels are not consistent with<br />
the image of the brand, do not provide service that consumers of<br />
( continued on page 7 )
( continued from page 6 )<br />
the brand would come to expect, undercut sales and potentially put<br />
pricing pressure on authorized retailers, and make it more difficult<br />
to identify and prevent sales of counterfeit goods. Nonetheless,<br />
brand owners by and large have been on the losing side of the legal<br />
battle challenging such conduct, as the products at issue fulfilled<br />
a fundamental principle of trademark law — that they are original<br />
goods emanating from the brand owner (i.e., the product is no different<br />
from that sold by authorized retailers). Put simply, courts held<br />
that consumers could not be confused about the origin of a good<br />
when the origin had not changed, just the sales outlet had. 2 Brand<br />
owners adopted and pressed alternative legal theories to stop<br />
such sales, such as tortious interference with contract (i.e., that<br />
the retailer tortiously interfered with the brand owners’ exclusive<br />
distribution relationships). But given the additional elements<br />
that a plaintiff must present to establish such a tort (i.e., retailer<br />
knowledge of the exclusive relationship and an intent to interfere<br />
with such relationship), and that the genuine goods frequently<br />
would travel through multiple parties such that the retailer would<br />
not have diverted the goods from the distributor that was subject<br />
to the contractual restriction with the brand owner, brand owners<br />
frequently failed here as well. Brand owners also resorted to<br />
self-help, by purchasing unauthorized product and attempting to<br />
trace its origins (and the cause of the diversion), but retail stores<br />
selling such unauthorized goods typically remove UPCs and similar<br />
identifying characteristics to avoid such detection. Challenges by<br />
brand owners that such UPC removal itself constituted trademark<br />
infringement by modifying the product such that it was no longer<br />
an original met with limited success. 3<br />
Such was the legal landscape when Zino Davidoff SA (Davidoff), the<br />
Switzerland-based manufacturer of luxury items, challenged CVS<br />
Corporation (CVS), the pharmacy chain, for its unauthorized sales<br />
of Davidoff’s Cool Water brand perfume. Davidoff distributes such<br />
fragrances to select high-end retailers in the United States. CVS was<br />
not an authorized retailer of the Cool Water fragrance, but was able<br />
to obtain Cool Water inventory through secondary distribution channels<br />
— i.e., the “gray market.” Cool Water fragrances were among<br />
CVS’s top-selling fragrances.<br />
On three different occasions over the years, Davidoff had discovered<br />
that, in addition to fragrances acquired via the gray market, CVS also<br />
was selling counterfeit Cool Water fragrances. After the third occasion,<br />
Davidoff sought and secured a temporary restraining order in<br />
the U.S. District Court for the Southern District of New York against<br />
CVS with respect to such counterfeit product. The court additionally<br />
authorized Davidoff to inspect all the undistributed Cool Water products<br />
in CVS’s inventory to investigate how pervasive the counterfeits<br />
were. During the course of the inspection, Davidoff discovered<br />
that the UPCs had been removed from the packaging of 16,600<br />
fragrances. Because Davidoff perceived the sale of these items to<br />
be a threat to its anti-counterfeiting measures, it sought a preliminary<br />
injunction preventing CVS from selling all Cool Water products with the<br />
UPC removed regardless of whether the product was genuine or not.<br />
The Court’s Decision<br />
The Southern District of New York granted a preliminary injunction<br />
and CVS appealed. The Second Circuit affirmed the preliminary<br />
injunction. The appellate court agreed with the district court that<br />
Davidoff likely would succeed in its trademark infringement claim,<br />
finding that CVS interfered with Davidoff’s right to control the<br />
quality of the product under the Lanham Act. The court ordered<br />
CVS to stop selling such items, genuine or not, with the UPC<br />
IP® EVIEW<br />
7<br />
removed. Davidoff introduced evidence that, as part of its quality<br />
control measures, the UPC on each fragrance package, which<br />
enables Davidoff to trace each product through the production<br />
and distribution line to final sale, helps identify and resolve quality<br />
issues as they arise. The Second Circuit stated that “because the<br />
UPC acts as a quality control mechanism which enables Davidoff<br />
to protect the reputation of its trademark by identifying counterfeits<br />
and by protecting against defects,” Davidoff was likely to succeed<br />
in its trademark infringement claim and a preliminary injunction<br />
accordingly was appropriate. 4<br />
The Second Circuit held that to establish a Lanham Act violation<br />
there need not be actual quality differences between the authorized<br />
goods and the gray-market goods — instead, the Lanham Act<br />
affords the trademark owner the right to control the quality of goods<br />
manufactured and sold bearing the mark. 5 The court endorsed the<br />
three-part test set forth in Warner-Lambert Co. v. Northside Development<br />
Corp., 6 to determine whether a holder’s right to control quality<br />
has been subverted:<br />
[A] trademark holder is entitled to an injunction against<br />
one who would subvert its quality control measures<br />
upon a showing that (i) the asserted quality control<br />
procedures are established, legitimate, substantial,<br />
and nonpretextual, (ii) it abides by these procedures,<br />
and (iii) sales of products that fail to conform to these<br />
procedures will diminish the value of the mark. 7<br />
The appellate court determined that Davidoff’s practice of regularly<br />
working with and training retailers, private investigators and U.S.<br />
Customs agents enhanced its effectiveness to detect and prevent<br />
the sales of counterfeits and to detect and recall defective goods; all<br />
of which worked toward meeting the first two prongs of the Warner<br />
test. 8 CVS argued that Davidoff’s UPC system is only a pretextual<br />
quality control mechanism and in reality its true purpose is to allow<br />
Davidoff to search out distributors of gray-market goods. The court,<br />
however, found the argument to be unconvincing based on evidence<br />
provided by Davidoff that it had in fact used its UPC system on<br />
many occasions to address quality control issues such as identifying<br />
counterfeits, under-filled or over-filled bottles, defective dispensers<br />
and improper packaging. 9<br />
In discussing the third prong, the appellate court noted that Davidoff<br />
is able to use the UPC system to identify counterfeit items by<br />
discovering items with UPCs that are not registered on its system. 10<br />
Although CVS argued that gray-market goods are not necessarily<br />
counterfeit goods, the court noted that gray-market goods that have<br />
the UPC removed make it almost impossible for trademark holders<br />
like Davidoff to discover counterfeit goods. 11 The court stated that<br />
anti-counterfeiting systems control — even if indirectly — the quality<br />
of a product because counterfeit goods are invariably inconsistent<br />
and lower in quality. 12<br />
Regarding direct quality control, the court found that the UPC<br />
system helps Davidoff to identify and recall genuine authorized but<br />
defective products. The UPC helps to identify where a product was<br />
manufactured and the batch which produced the defect, and helps<br />
facilitate targeted recall. Removing the UPC from a product could<br />
prevent Davidoff from tracking the instances of inconsistency and<br />
defect among its genuine fragrances. This interference alone, the<br />
court held, is a violation of Davidoff’s right as trademark holder to<br />
control the quality of its product. 13<br />
( continued on page 8 )
( continued from page 7 )<br />
Impact<br />
For the luxury manufacturer, this case signifies that anti-counterfeiting<br />
systems can constitute quality control procedures. Tampering with<br />
those systems could interfere with a trademark holder’s right to<br />
control the quality of its product and maintain the value of its mark,<br />
and such conduct in and of itself may constitute trademark infringement,<br />
at least in the Second Circuit. In light of this decision, luxury<br />
item manufacturers that utilize a UPC-like system for their products<br />
may be successful in seeking a preliminary injunction in the Second<br />
Circuit against retailers that resell even genuine products but do so<br />
by obfuscating or removing UPCs. �<br />
1 Zino Davidoff SA v. CVS Corp., 2009 U.S. App. LEXIS 13172 (2d Cir. N.Y. June 19,<br />
2009).<br />
2 E.g., Enesco Corp. v. Price/Costco Inc., 146 F.3d 1083, 1085 (9th Cir. 1998).<br />
3 See Davidoff & Cie v. PLD International Corporation, 263 F.3d 1297, 1303 (11th Cir.<br />
2001) (a defacement of UPCs on a bottle that “degrades the appearance” of the<br />
product may constitute trademark infringement).<br />
4 Id. at 2.<br />
5 El Greco Leather Products v. Shoe World, Inc., 806 F.2d 392, 395 (2d Cir. 1986)<br />
(emphasis added).<br />
6 86 F.3d 3, 39 (2d Cir. 1996).<br />
7 Zino Davidoff, 2009 U.S. App. LEXIS 13172 at *16.<br />
8 Id. But note that Warner-Lambert involved product that was being sold beyond its<br />
expiry date, and accordingly arguably no longer was genuine.<br />
9 Id. at *18.<br />
10 Id. at *14.<br />
11 Id. at *17.<br />
12 Id. at *15.<br />
13 Id. at *17-19.<br />
Federal Circuit Issues Two Key Decisions<br />
Clarifying Rights of Patent Licensees<br />
On May 22, 2009, the Federal Circuit issued two decisions clarifying<br />
the scope of rights conferred by patent license agreements, ruling in<br />
favor of the patent licensee in both cases. In the first, Epistar Corp.<br />
v. Int’l Trade Comm’n, Case No. 2007-1457, the court held that a<br />
covenant not to challenge patent validity in a settlement or license<br />
agreement was binding against successors-in-interest only to the<br />
extent that it could have been enforced against the original licensee.<br />
As such, a future assignee of a patent license retains the right to<br />
assert a defense of patent invalidity in contexts that are outside the<br />
scope of the original license agreement. In the second decision,<br />
CoreBrace LLC v. Star Seismic LLC, Case No. 2008-1502, the court<br />
determined that a license to make, use, and sell a patented product<br />
necessarily included an implied license to have that product made<br />
by a third party. Both of these decisions will undoubtedly impact<br />
the legal and commercial analyses that business entities must<br />
undertake when entering into agreements or considering corporate<br />
mergers or acquisitions.<br />
Epistar Corp. v. Int’l Trade Comm’n<br />
On November 4, 2005, Philips Lumileds Lighting Company<br />
(Lumileds) alleged infringement of U.S. Patent No. 5,008,718 (the<br />
‘718 patent) against Epistar Corporation (Epistar) and United Epitaxy<br />
Company (UEC) in the International Trade Commission (ITC). Prior<br />
IP® EVIEW<br />
8<br />
to the filing of that action, Lumileds had entered into two separate<br />
license agreements with Epistar and UEC, respectively, which<br />
covered some (but not all) of the products manufactured by these<br />
two entities. The license with UEC included the right to use the ‘718<br />
patent for the manufacture, sale and importation of light emitting<br />
diodes, and also contained a covenant not to challenge the ‘718<br />
patent’s validity. The license with Epistar, covering a different set of<br />
products, preserved Epistar’s right to challenge validity with respect<br />
to any Epistar products that might later be accused of infringement.<br />
Two months after the ITC action was filed, UEC merged into Epistar,<br />
with UEC ceasing to exist as a separate company, and with Epistar<br />
assuming all of “UEC’s assets, liabilities, contractual and patent-<br />
related rights and obligations, and UEC’s status as a party to the<br />
Commission investigation,” including UEC’s license with Lumileds.<br />
After the merger, Epistar continued to manufacture its own light<br />
emitting diodes, along with UEC’s products and three next-generation<br />
diode products.<br />
The ITC found that “Epistar, like UEC, is barred from raising an<br />
invalidity defense to the assertion of infringement of the ‘718 patent<br />
against any product” because “Epistar, like UEC, would be contractually<br />
estopped from raising an invalidity defense to the ‘718 patent.”<br />
The Federal Circuit reversed this finding, holding that “Epistar (as<br />
successor to UEC) may not contest the validity of the ‘718 patent<br />
with respect to the UEC products that it inherited in the merger,”<br />
but this restriction would have no effect on Epistar’s right to challenge<br />
the ‘718 patent when other products are at issue. As such,<br />
“Epistar’s acquisition of UEC does not have the effect of limiting<br />
Epistar’s rights that are unrelated to the product lines it acquired<br />
from UEC.”<br />
While this case involves some unique circumstances, including<br />
the fact that Epistar had its own license agreement with Lumileds<br />
which contained no covenant against challenging validity, the court’s<br />
analysis suggests that its ruling applies to a broad range of commercial<br />
relationships. For instance, the court notes that “[b]lack letter<br />
contract law states that the assignment of a contract to an assignee,<br />
such as from UEC to Epistar, only changes the obligated party, not<br />
the scope of the obligation.” Given these underlying principles, it<br />
appears that even if there had been no separate agreement preserving<br />
the right to contest validity, the merger of UEC and Epistar<br />
would not have eliminated Epistar’s ability to challenge the validity of<br />
the ‘718 patent in all contexts.<br />
CoreBrace LLC v. Star Seismic LLC<br />
In CoreBrace, defendant Star Seismic LLC (Star) had received a<br />
license in 2007 to U.S. Patent No. 7,188,452 (the ‘452 patent) from<br />
the predecessor-in-interest to plaintiff CoreBrace LLC (CoreBrace).<br />
On January 4, 2008, CoreBrace sent a letter to Star stating that<br />
the license was terminated based upon Star’s use of third-party<br />
contractors to manufacture licensed products for Star’s own use,<br />
which CoreBrace contended was a breach of the license. On that<br />
same day, CoreBrace filed suit for patent infringement. The district<br />
court granted a Rule 12(b)(6) motion to dismiss, after determining<br />
that Star was entitled to use third-party contractors to make the<br />
licensed products, without such action constituting a breach of<br />
the license.<br />
The Federal Circuit affirmed the district court’s dismissal, concluding<br />
that “[t]he right to ‘make, use, and sell’ a product inherently includes<br />
the right to have it made by a third party, absent a clear indication<br />
( continued on page 9 )
( continued from page 8 )<br />
of intent to the contrary.” Although the case nominally involved the<br />
application of Utah’s contractual laws, the Federal Circuit’s holding<br />
was based broadly on what it identified as complete agreement<br />
among courts that had considered analogous circumstances, “that a<br />
‘have made’ right is implicit in a right to make, use, and sell, absent<br />
an express contrary intent.” Indeed, the Federal Circuit reached<br />
this conclusion despite the fact that the licensee between Star and<br />
CoreBrace included a “reservation of rights” clause. Thus, without<br />
a showing of “clear intent to exclude ‘have made’ rights from the<br />
License,” a patent licensor cannot sue for infringement based upon<br />
the actions of a third party who is manufacturing licensed products<br />
on behalf of the licensee.<br />
Importance of Epistar and CoreBrace<br />
Each of these decisions offers considerable guidance to commercial<br />
entities when drafting agreements and when assessing<br />
the intellectual property aspects of contemplated mergers and<br />
acquisitions. In both of these cases, the licensee “won” — but in<br />
each case, the Federal Circuit’s opinion suggests that a different<br />
outcome could have been reached had the license agreements at<br />
issue been drafted differently. Thus, these cases offer crucial guidance<br />
and clarity to parties on both sides of a potential or existing<br />
license agreement.<br />
Commercial entities must be cognizant that a covenant against<br />
challenging patent validity ultimately may not be enforceable in<br />
all contexts against a license assignee. This will undoubtedly<br />
affect the valuation of potential targets and the likelihood that the<br />
acquiring party will one day be held liable for patent infringement<br />
of a valid claim. In addition, when drafting license agreements,<br />
parties must be aware of the scope and limitations of any covenants<br />
made on behalf of the licensee, which the Federal Circuit<br />
has indicated will be strictly interpreted, at least in the context of<br />
a merger.<br />
Likewise, the Federal Circuit also has created a brightline rule with<br />
respect to the manufacturing of licensed products by third parties<br />
— there must be a clear indication that the license does not extend<br />
to such third-party activities; a reservation of rights clause is insufficient.<br />
This may require parties on both sides of license agreements<br />
(or potential license agreements) to discuss issues of third-party<br />
manufacturing and assess whether this issue should be explicitly<br />
addressed in the agreement. �<br />
ISPs Immunity From Contributory<br />
Infringement Not Absolute<br />
Courts in the United States repeatedly have failed to hold Internet<br />
service providers (ISPs) liable for contributory infringement based on<br />
their hosting of Web sites — until now. In Louis Vuitton Malletier,<br />
S.A. v. Akanoc Solutions, Inc., et al., 1 a jury in the Northern District<br />
of California found two ISPs liable for $32.4 million in damages for<br />
contributory trademark and copyright infringement when they failed<br />
to take down sites selling counterfeit goods. This verdict presents<br />
both an opportunity for brand owners seeking to stop the distribution<br />
of infringing goods on the Internet, and an area of vulnerability for<br />
ISPs that host sites offering such goods. It also creates a distinction<br />
between how courts in the Second Circuit and the Ninth Circuit view<br />
such activities.<br />
IP® EVIEW<br />
9<br />
Background<br />
The plaintiff, Louis Vuitton Malletier, S.A. (LV or the company), is a<br />
well-known designer and distributor of luxury handbags, luggage<br />
and other leather goods best known for bearing the distinctive “LV”<br />
trademark. Within the United States, the company is the sole and<br />
exclusive distributor of its products, which it sells online through a<br />
single Web site operated by the company. 2<br />
The defendants, Akanoc Solutions, Inc. (Akanoc) and Managed<br />
Solutions Group, Inc. (MSGI) are ISPs that sell IP addresses and host<br />
Web sites. A third defendant, Steven Chen, owns, operates and<br />
controls both Akanoc and MSGI. According to LV, most, if not all, of<br />
the Web sites hosted by the defendants are engaged in the sale of<br />
counterfeit merchandise. 3<br />
In 2006 and 2007, LV learned that over 70 Web sites hosted on the<br />
defendants’ servers were selling counterfeit goods bearing “LV”<br />
trademarks. 4 For a period of more than six months, the company<br />
sent the defendants numerous letters demanding that the Web sites<br />
be taken down. The defendants failed to respond to any of LV’s<br />
requests and thus the majority of the offending Web sites were not<br />
taken offline until after LV filed a lawsuit. 5<br />
The company brought an action in federal district court alleging (1)<br />
contributory trademark infringement; (2) vicarious trademark infringement;<br />
(3) contributory copyright infringement; and (4) vicarious<br />
copyright infringement. The district court granted the defendants’<br />
motion for summary judgment on the vicarious infringement<br />
claims, but denied it with respect to the contributory trademark and<br />
copyright infringement claims, finding there was evidence that the<br />
defendants had actual knowledge of, and continued to support, the<br />
counterfeiting Web sites.<br />
The Jury’s Verdict<br />
After a trial on the merits, the jury found all three defendants liable<br />
for contributory trademark and copyright infringement. Specifically,<br />
the jurors found that after repeated notices from LV, defendants<br />
knew or should have known that customers were using their services<br />
to infringe LV’s intellectual property. Instead of taking action to<br />
stop such activities by ceasing to host the Web sites, the defendants<br />
ignored the requests and continued to provide the services, thereby<br />
contributing to the damages suffered by LV.<br />
The jury further rejected the defendants’ arguments that the safe harbor<br />
provisions of the Digital Millennium Copyright Act (DMCA) insulated<br />
them from liability. The DMCA holds ISPs whose services are used<br />
to commit infringement 6 immune from legal liability for such activities<br />
when they establish and follow a “notice and takedown” process<br />
to respond to complaints and remove infringing material in a timely<br />
manner. It does not, however, protect an ISP that is “aware of facts or<br />
circumstances from which infringing activity is apparent” or “receive[s]<br />
a financial benefit directly attributable to the infringing activity.” 7 As<br />
discussed above, the jury was convinced that the defendants were<br />
aware of the infringing activity and rather than stop it, instead chose to<br />
continue to receive hosting fees and enable the infringement.<br />
In determining damages, the jury found that the defendants acted<br />
willfully, and thus awarded LV $31.5 million on the contributory<br />
trademark and $900,000 on the contributory copyright infringement<br />
claims. The district court is expected to issue a permanent injunction<br />
prohibiting defendants from hosting Web sites selling counterfeit<br />
Louis Vuitton goods.<br />
( continued on page 10 )
( continued from page 9 )<br />
Split in the Circuits’ Views<br />
Prior to the Louis Vuitton case, ISPs generally were well shielded by<br />
judicial interpretations of the DMCA’s safe harbor. Additionally, no<br />
court or jury previously had found an ISP liable for contributory trademark<br />
infringement where customers used the ISP’s services to sell<br />
counterfeit or infringing goods. In fact, in July 2008, the U.S. District<br />
Court for the Southern District of New York held in Tiffany, Inc. v.<br />
eBay, Inc., 8 a case with certain similar facts, that online marketplace<br />
eBay, Inc. was not liable for contributory trademark infringement.<br />
The case is on appeal to the U.S. Court of Appeals for the Second<br />
Circuit, which heard oral arguments in July 2009.<br />
In Tiffany v. eBay, after conducting a bench trial on the merits, the<br />
court was not convinced that luxury jeweler Tiffany, Inc.’s repeated<br />
mailing of demand letters to eBay and its submission of eBay’s<br />
Notice of Claimed Infringement (NOCI) forms notifying eBay that<br />
counterfeit Tiffany products were sold on its marketplace were<br />
sufficient to establish eBays’ knowledge of the infringement. The<br />
court determined that Tiffany’s demand letters only gave eBay generalized<br />
knowledge rather than knowledge of specific instances of<br />
infringement, and thus were not sufficient to establish a contributory<br />
trademark infringement claim. As discussed above, this is in direct<br />
contrast to the Louis Vuitton case, where the jury believed that LV’s<br />
demand letters were sufficient to find that the defendants knew or<br />
should have known of specific instances of infringement.<br />
Another fact worth noting is the difference in the respective<br />
defendants’ responses to the plaintiffs’ demand letters. In Tiffany<br />
v. eBay, the defendant maintained extensive anti-fraud measures<br />
and responded to each of Tiffany’s NOCI forms by investigating and<br />
ultimately removing the listings for counterfeit goods. Therefore,<br />
the court concluded that, even assuming the demand letters could<br />
constitute specific knowledge, the defendant took prompt steps to<br />
stop the infringement. In contrast, the defendants in Louis Vuitton<br />
did not respond to the demand letters and failed to promptly cease<br />
hosting the sites selling counterfeit goods.<br />
Impact<br />
It will be interesting to see if and how the Ninth and Second Circuits<br />
resolve their different approaches to the issue of sufficient notice<br />
under the DMCA. In the meantime, the jury’s verdict in Louis<br />
Vuitton could create a helpful new avenue for companies struggling<br />
to protect their brands and intellectual property from infringement on<br />
the Internet. In light of the case, intellectual property owners should<br />
not only notify ISPs of infringement, but continue to send demand<br />
letters to nonresponsive ISPs, as courts may view such actions as<br />
evidence of contributory infringement. The case also should serve<br />
as a reminder for ISPs that the safe harbor protections of the DMCA<br />
are not absolute. Turning a blind eye toward intellectual property<br />
owners’ take-down requests may render an ISP liable for willful<br />
contributory infringement and subject it to large damage awards. �<br />
1 Verdict, Louis Vuitton Malletier, S.A. v. Akanoc Solutions, Inc., et al., No. C 07-03952<br />
JW (N.D. Cal. Aug. 28, 2009).<br />
2 See Amended Complaint, supra note 1, at 8-9.<br />
3 See id. at 31.<br />
4 See Order Granting in Part and Denying in Part Defendants’ Motion for Summary<br />
Judgment, supra note 1, at 2-3.<br />
5 See Declaration of Nikolay Livadkin in Support of Opposition to Defendants’ Motion<br />
for Summary Judgment, supra note 1, at 12-19.<br />
IP® EVIEW<br />
10<br />
6 See 17 U.S.C. § 512 (2008).<br />
7 Id. § 512(c)(1).<br />
8 576 F. Supp. 2d 463 (S.D.N.Y. 2008), appeal docketed, No. 08-3947-cv (2d Cir. filed<br />
Aug. 11, 2008).<br />
SEC Imposes $100,000 Fine for Firm’s Failure<br />
to Safeguard Customer Information<br />
The Securities and Exchange Commission (SEC) recently intensified<br />
its efforts to ensure that firms implement adequate measures<br />
to protect customers’ nonpublic personal information. On September<br />
29, 2009, the SEC issued a cease and desist order pursuant<br />
to Sections 15(b) and 21C of the Securities Exchange Act of 1934,<br />
and Sections 203(e) and 203(k) of the Investment Advisers Act of<br />
1940 against a registered broker-dealer/investment adviser that<br />
failed to safeguard customer information. 1 The SEC also ordered<br />
the firm, Commonwealth Equity Services, LLP d/b/a Commonwealth<br />
Financial Network (Commonwealth), to pay a civil money<br />
penalty of $100,000.<br />
Background<br />
Rule 30(a) of Regulation S-P (the Safeguards Rule) 2 requires brokerdealers<br />
and SEC-registered investment advisers to adopt written<br />
policies and procedures that address administrative, technical and<br />
physical safeguards for the protection of customer records and information.<br />
Specifically, these written policies and procedures must be<br />
reasonably designed to: (1) ensure the security and confidentiality of<br />
customer records and information; (2) protect against any anticipated<br />
threats or hazards to the security or integrity of customer records<br />
and information; and (3) protect against unauthorized access to or<br />
use of customer records or information that could result in substantial<br />
harm or inconvenience to any customer. 3<br />
Commonwealth retains approximately 1,600 licensed brokers<br />
as independent contractors (registered representatives). Each<br />
registered representative received Commonwealth’s written policies<br />
and procedures, which were intended to safeguard customer<br />
records and information. These policies required each representative<br />
to maintain the security of the information entrusted to that<br />
representative. In connection with such requirement, the policies<br />
recommended that the registered representatives install anti-virus<br />
software on computers used by the representatives to access<br />
customer account information.<br />
In November 2008, an unauthorized party hacked into a registered<br />
representative’s computer, obtained the representative’s login<br />
credentials and used the credentials to access customer account<br />
information. The intruder then entered several unauthorized purchase<br />
orders for which Commonwealth absorbed monetary losses.<br />
Notably, the representative whose computer was hacked had called<br />
Commonwealth’s IT help desk several times before the incident.<br />
For example, in September 2008, the representative called the help<br />
desk for assistance with a potential software virus. The help desk<br />
was unable to detect anti-virus software on the representative’s<br />
computer, but only “recommended” that the representative install<br />
such software. The help desk did not do any follow up, and the<br />
representative never installed the software. The lack of anti-virus<br />
software allowed the intruder to hack the representative’s computer<br />
and access customer information.<br />
( continued on page 11 )
( continued from page 10 )<br />
In anticipation of the SEC proceedings, Commonwealth submitted<br />
an Offer of Settlement. The SEC accepted Commonwealth’s offer<br />
and entered the order instituting administrative and cease and desist<br />
proceedings. Commonwealth consented to the order without admitting<br />
or denying any of the findings in the order.<br />
SEC Order<br />
The SEC found that Commonwealth willfully violated the Safeguards<br />
Rule by recommending, but not requiring, that its registered representatives<br />
maintain anti-virus software on their computers. As a<br />
result, Commonwealth’s customer information was left vulnerable,<br />
and such vulnerability was successfully exploited.<br />
Commonwealth also was found not to have procedures in place to<br />
adequately review its representatives’ computer security measures.<br />
In particular, Commonwealth did not audit its representatives’<br />
computers to determine whether anti-virus software was installed.<br />
Additionally, Commonwealth did not have procedures in place to<br />
follow up on potential computer security issues uncovered during<br />
audits or when representatives notified Commonwealth of the issue.<br />
Impact<br />
The SEC order against Commonwealth comes at a time when<br />
state and federal regulators are paying increased attention to data<br />
breaches, and serves as an important reminder that firms must pay<br />
careful attention to this area. The order reiterates that companies<br />
are not only responsible for their own systems, but for the systems<br />
of independent contractors, even where independent contractors<br />
provide their own computer and software. Firms must also ensure<br />
that their security measures protect against unauthorized access to<br />
customer records, and must implement policies to address security<br />
issues that arise. In particular, firms registered with the SEC must<br />
put these procedures in writing to ensure compliance with the<br />
Safeguards Rule. �<br />
1 See Release No. 34-60733.<br />
2 17 C.F.R. A7 248.30(a). The Safeguards Rule became effective on November 13,<br />
2000, and compliance has been mandatory since July 1, 2001.<br />
3 Id.<br />
The Reign of Bilski ( from page 1 )<br />
The Bilski Decision<br />
The Federal Circuit’s en banc decision arose from a patent application<br />
with claims directed to methods of hedging risk in the field of<br />
commodities trading. During prosecution, all of the pending claims<br />
were rejected by the Patent Office (PTO) under Section 101 of the<br />
Patent Act. Section 101 provides that:<br />
Whoever invents or discovers any new and useful<br />
process, machine, manufacture, or composition of<br />
matter, or any new and useful improvement thereof, may<br />
obtain a patent therefor, subject to the conditions and<br />
requirements of this title.<br />
35 U.S.C. § 101. Section 101 recites four categories of patenteligible<br />
subject matter: processes, machines, manufactures and<br />
compositions of matter. Although the applicants contended that<br />
IP® EVIEW<br />
11<br />
their claims were directed to a “new and useful process,” the PTO<br />
and the Board of Patent Appeals and Interferences (BPAI) disagreed.<br />
Upon appeal, the en banc Federal Circuit affirmed the rejection of the<br />
pending claims, with nine circuit judges joining the majority opinion,<br />
two judges filing dissenting opinions agreeing with the ultimate outcome<br />
but offering a different rational, and one judge filing a lengthy<br />
dissent without expressing a view as to whether the claims were<br />
drawn to patent-eligible subject matter under Section 101. Despite<br />
the multiple opinions, the Federal Circuit judges all agreed, following<br />
prior decisions of the Supreme Court, that the meaning of the term<br />
“process” in Section 101 is narrower than its ordinary meaning.<br />
“Specifically, the Court has held that a claim is not a patent-eligible<br />
‘process’ if it claims ‘laws of nature, natural phenomena, [or] abstract<br />
ideas.’” Bilski, 545 Fed. Cir. at 952 (quoting Diamond v. Diehr, 450<br />
U.S. 175, 185 (1981)). However, the various opinions debated what<br />
test or set of criteria governed the determination as to when a process<br />
was improperly claiming a law of nature, natural phenomena,<br />
mental process or an abstract idea.<br />
The majority opinion set forth the following test in an attempt to<br />
answer that question. The Federal Circuit held that a “claimed<br />
process is surely patent-eligible under Section 101 if: (1) it is tied<br />
to a particular machine or apparatus, or (2) it transforms a particular<br />
article into a different state or thing.” Bilski, 545 F.3d at 954<br />
(emphasis in original). The court explained that “the use of a specific<br />
machine or transformation of an article must impose meaningful<br />
limits on the claim’s scope to impart patent-eligibility” and “the<br />
involvement of the machine or transformation in the claimed process<br />
must not merely be insignificant extra-solution activity.” Id. at<br />
961-62. Thus, the transformation of a particular article into a different<br />
state or thing “must be central to the purpose of the claimed<br />
process.” Id. In further explaining the “machine-or-transformation”<br />
test, the Federal Circuit explained that “mere field-of-use limitations<br />
are generally insufficient to render an otherwise ineligible process<br />
claim patent-eligible,” as such limitations indicate that a claim is not<br />
limited to a specific application of a fundamental principle. Id. at 957.<br />
The Federal Circuit’s “machine-or-transformation” test was adopted<br />
to the exclusion of the Freeman-Walter-Abele test 1 , the “useful,<br />
concrete and tangible result” test 2 , and a “technological arts” test<br />
proposed by several amici.<br />
Applying the machine-or-transformation test, the Federal Circuit<br />
held that the applicants’ claims failed to satisfy the first prong of<br />
the test (process tied to a particular machine) as the applicants<br />
admitted that their pending claims were not limited to any specific<br />
machine or apparatus. Id. at 962. The Federal Circuit also held<br />
that the applicants’ claims did not transform any article to a different<br />
state or thing. In particular, the Federal Circuit held that<br />
manipulation of “legal obligations or relationships, business risks,<br />
or other such abstractions cannot meet the test because they are<br />
not physical objects or substances, and they are not representative<br />
of physical objects or substances.” Id. at 963. In short, the<br />
applicants’ claims were rejected since they sought “to claim a nontransformative<br />
process that encompasses a purely mental process<br />
of performing requisite mathematical calculations without the aid of<br />
a computer or any other device, mentally identifying those transactions<br />
that the calculations have revealed would hedge each other’s<br />
risks, and performing the post-solution step of consummating<br />
those transactions.” Id. at 965. With this decision, the Federal<br />
Circuit opened the door to a greater number of invalidity challenges<br />
based on Section 101.<br />
( continued on page 12 )
( continued from page 11 )<br />
Post-Bilski Decisions by the Federal Circuit<br />
Although not mentioning Bilski, the Federal Circuit applied Section<br />
101 to affirm the rejection of a large number of claims directed to<br />
methods for mandatory arbitration in In re Comiskey, 554 F.3d 967<br />
(Fed. Cir. 2009). In particular, the rejected claims recited methods<br />
or systems for mandatory arbitration involving legal documents. The<br />
claims did not require the use of a mechanical device such as a computer.<br />
After addressing prior Section 101 jurisprudence, the Federal<br />
Circuit reiterated that the term “process” as used in the Patent<br />
Act did not actually encompass all things that could be considered<br />
processes. The Federal Circuit held that Comiskey’s method claims<br />
were not patent-eligible because they recited business systems that<br />
depended entirely on the use of mental processes and abstract ideas.<br />
In its first decision subsequent to Bilski that applied the machineor-transformation<br />
test, the Federal Circuit confirmed the rejection<br />
of claims directed to methods of marketing products and claims<br />
directed to “paradigms” for marketing. See In re Ferguson, 558<br />
F.3d 1359 (Fed. Cir. 2009). The Federal Circuit held that the<br />
methods for marketing did not satisfy either prong of the machineor-transformation<br />
test and reiterated that this was the sole test for<br />
judging the patent eligibility of method claims. 3 The methods were<br />
not tied to any particular machine or apparatus (“a marketing force<br />
is not a machine”). Id. at 1364. Furthermore, the methods did not<br />
transform any article into a different state or thing — organizing<br />
business or legal relationships in the structuring of a sales force is<br />
not transforming a physical object or substance. Id. With regard<br />
to the “paradigm” claims, the Federal Circuit rejected those claims<br />
as covering nonstatutory subject matter in that they only provided<br />
an abstract idea — “a business model for an intangible marketing<br />
company.” Id. at 1366.<br />
In its most recent decision applying Section 101, the Federal Circuit<br />
reversed a district court’s determination that claims directed to a<br />
method of optimizing therapeutic efficacy for a particular disorder<br />
were invalid as directed to nonstatutory subject matter. In Prometheus<br />
Labs., Inc. v. Mayo Collaborative Servs., 581 F.3d 1336,<br />
2009 U.S. App. LEXIS 20623 (Fed. Cir. Sept. 16, 2009), the claims at<br />
issue were directed to methods of optimizing treatment comprising the<br />
steps of (1) administering a particular drug to a subject (“providing<br />
6-thioguanine”) and (2) determining the level of certain metabolites<br />
in the subject as a result of the administering step. The claims<br />
also recited several “wherein” clauses that suggested, but did not<br />
require, either a need to increase or decrease further administration<br />
of the drug based on the determining step.<br />
Applying the machine-or-transformation test, the Federal Circuit held<br />
that the claims were patent-eligible because they transformed an<br />
article into a different state or thing. “The transformation is one of<br />
the human body following administration of a drug and the various<br />
chemical and physical changes of the drug’s metabolites that enable<br />
their concentrations to be determined.” Prometheus Labs., 2009<br />
U.S. App. LEXIS 20623 at *22-23. The Federal Circuit indicated that<br />
administering drugs as a method of treatment is “always transformative”<br />
when attempting to treat the effects of a medical condition. Id.<br />
at *23. The Federal Circuit rejected the notion that the administering<br />
and determining steps amounted to mere data gathering and as such<br />
did not fall within the scope of patentable subject matter. Instead,<br />
the steps were considered to be “part of a treatment protocol”<br />
and as such were transformative. Id. at *28. With regard to the<br />
“wherein” clauses, the Federal Circuit held that those statements<br />
did not render the claims outside the scope of the Patent Act even<br />
IP® EVIEW<br />
12<br />
though they suggested mental processes used to determine the<br />
need to change drug dosage levels in the future. Reiterating its<br />
discussion in Bilski, the Federal Circuit noted that it is irrelevant<br />
whether any individual step or limitation in a process claim would be<br />
unpatentable by itself. Id. at *30-31. When the claims are viewed<br />
as a whole, the mental steps recited in the “wherein” clauses did<br />
not negate the transformative aspects of the “administering” and<br />
“determining” steps in the claim. Id. at *30-32. 4<br />
Post-Bilski Decisions by District Courts<br />
Following the example set by the Federal Circuit, several district<br />
court decisions demonstrate that district court judges are willing<br />
to find claims invalid under Section 101 when they do not meet<br />
the “machine-or-transformation” test. In Fort Properties, Inc. v.<br />
American Master Lease, LLC, 609 F. Supp. 2d 1052 (C.D. Cal. 2009),<br />
the court held that all claims of a patent directed to methods of<br />
conducting transactions for acquiring real estate were invalid under<br />
Section 101. Since the applicant admitted during prosecution that<br />
the methods could be performed without the use of a computer, the<br />
court proceeded to review whether the claims met the transformation<br />
prong of the Bilski test. “Like the claims at issue in Bilski,<br />
the claims of the ‘788 Patent involve only the transformation or<br />
manipulation of legal obligations and relationships. Specifically,<br />
the claims of the ‘788 Patent only transform or manipulate legal<br />
ownership interests in real estate. Under Bilski, the Court cannot<br />
find that those claims transform an article or thing.” Fort Properties,<br />
609 F. Supp. 2d at 1056. 5 While the claims did recite the creation of<br />
“deedshares,” the court held that the deedshares were not physical<br />
objects, but instead were conceptual legal rights that may or may not<br />
be printed on paper. Id.<br />
In Cybersource Corp. v. Retail Decisions, Inc., 620 F. Supp. 2d 1068<br />
(N.D. Cal. 2009), the district court held that two claims — one<br />
directed to a method for verifying the validity of credit card transactions<br />
“over the Internet,” and another claim directed to a “computerreadable<br />
medium containing program instructions for detecting fraud<br />
in a credit card transaction” — were invalid under Section 101. In<br />
invalidating the method claim, the court determined that “manipulation”<br />
of credit card numbers to construct a data structure useful in<br />
detecting fraud was not patent-eligible. “There is no indication that<br />
the Federal Circuit, having reaffirmed the machine-or-transformation<br />
test, intended to weaken the key term ‘transformation’ by equating<br />
it with mere ‘manipulation.’” Cybersource Corp., 620 F. Supp. 2d at<br />
1073. The court determined that neither the credit card numbers<br />
nor the credit cards were “transformed.” “Simply collecting data<br />
into a vague sort of ‘map’ does not amount to a ‘transformation.’”<br />
Id. at 1074. Furthermore, the court held that the credit card number<br />
represented an account and not a physical object: “Both the number<br />
and the card represent a common underlying abstraction — a credit<br />
card account, which is a series of rights and obligations existing<br />
between an account holder … and a card issuer.” Id. Analogizing this<br />
to Bilski, the court commented that a “piece of paper upon which the<br />
terms of an option are written is, like a credit card, a physical object.<br />
Yet this connection to a physical medium does not create patent<br />
eligibility, because an option ultimately represents the abstraction of a<br />
legal obligation or business risk. … Like options or deedshares, credit<br />
card accounts represent sets of legal rights and relationships, not<br />
‘articles.’” Id.<br />
The method claim in Cybersource Corp. was held invalid notwithstanding<br />
that it recited steps for use “over the Internet” and utilized<br />
“an Internet address” as part of a method for verifying the validity of<br />
( continued on page 13 )
( continued from page 12 )<br />
a transaction. The district court held that the claimed method was<br />
not statutory as the method did not transform or manipulate an IP<br />
address. “The IP address itself is not an object of transformation;<br />
indeed, it would make no sense to change the IP address, since its<br />
purpose is to serve as an identifier.” Id. at 1076.<br />
The “computer-readable medium” claim contained the same limitations<br />
regarding credit card numbers and the use of IP addresses. It<br />
also recited the use of “one or more processors” to carry out certain<br />
steps. Nonetheless, the court held that this claim was invalid because<br />
it was not implemented on a particular machine. The court rejected<br />
the idea that the “Internet” was a particular machine: “the internet is<br />
an abstraction. If every computer user in the world unplugged from<br />
the internet, the internet would cease to exist, although every molecule<br />
of every machine remained in place. One can touch a computer or a<br />
network cable, but one cannot touch ‘the internet.’” Id. at 1077. The<br />
court also concluded that the use of the “Internet” was insignificant<br />
extra-solution activity and constituted an attempt to make nonstatutory<br />
subject matter patent-eligible simply by limiting the claim to a particular<br />
technological field. Id. at 1077-78. Finally, the court held that simply<br />
adding the phrase “a computer-readable medium” to an otherwise nonstatutory<br />
process claim is insufficient to make it statutory. Id. at 1079.<br />
In Every Penny Counts, Inc. v. Bank of America Corp., 2009 U.S.<br />
Dist. LEXIS 53626 (M.D. Fla. May 27, 2009), the claim at issue<br />
concerned a “system,” including a network with various means for<br />
accomplishing certain tasks (e.g., “entry means … for entering into<br />
the network an amount being paid in a transaction”). The patentee<br />
argued that since the claim was directed to a “system” containing<br />
several “means,” the claim was directed to a machine — a category<br />
of patentable subject matter not addressed by Bilski. Despite the<br />
language of the claim, the court held that the patent was directed<br />
to a process and not a machine. According to the district court,<br />
the claim was directed to “a mathematical algorithm [that] uses<br />
machines for data input and data output and to perform the required<br />
calculations. Those machines do not, however, impose any limit on<br />
the process itself. The involvement of the machine in the process<br />
is insignificant extra-solution activity and thus the process is not<br />
patentable under § 101.” Every Penny Counts, 2009 U.S. Dist.<br />
LEXIS 53626 at *7. The court held that the steps of the claim did not<br />
transform any article into something different, and that the process<br />
was not tied to a particular computer or other device. Id. at *8.<br />
Accordingly, the court held the claim invalid under Section 101.<br />
In DealerTrack, Inc. v. Huber, 2009 U.S. Dist. LEXIS 58125 (C.D. Cal.<br />
July 7, 2009), the court held that patent claims directed to computeraided<br />
methods of managing credit applications were invalid under<br />
Section 101. The sole question concerned whether the method<br />
claims were tied to a particular machine, as the plaintiff apparently<br />
conceded that the transformation prong of Bilski was not met. Id.<br />
at *8-9. The claims at issue did recite a “computer aided method,”<br />
including receiving data from “a remote application entry and display<br />
device” and forwarding that data “to remote funding source terminal<br />
devices.” Nonetheless, the court held that the claims were invalid<br />
because “none of these devices constitutes a ‘particular machine’<br />
within the meaning of Bilski.” Id. at *12. Referencing its earlier<br />
claim construction ruling, the court noted that the “remote application<br />
entry” device and “remote funding” devices included any device<br />
“such as a personal computer or dumb terminal, and these devices<br />
clearly cannot constitute particular machines.” Id. at *13. 6<br />
In Research Corp. Technologies, Inc. v. Microsoft Corp., 2009 U.S.<br />
Dist. LEXIS 71883 (D. Az. July 28, 2009), the court rendered a<br />
IP® EVIEW<br />
13<br />
split decision, holding two patents invalid under Section 101, but<br />
confirming the patentability of three other patents under Section<br />
101. Two patents contained claims that were directed to methods<br />
of “halftoning” images by utilizing pixel-by-pixel comparisons of<br />
an image against a particular mask. In addressing these claims,<br />
the court noted that the “only component that could require a<br />
‘machine’ in the patents is the pixel-by-pixel comparison.” Id. at *35.<br />
However, the court noted that this comparison does not necessarily<br />
require a machine, but “instead it could be done on a sheet of paper<br />
using a pen.” Id. at *37. “The patent claims for the [] patents do<br />
not mandate the use of a machine to achieve their algorithmic and<br />
algebraic ends. Simply because a digital apparatus such as a computer,<br />
calculator, or the like could assist with this comparison does<br />
not render it patent-eligible material. RCT’s argument that a pixel<br />
by its nature is electronic and therefore necessitates a machine is a<br />
post solution argument and the Court rejects it.” Id. After finding<br />
that these claims were not tied to a particular machine, the court<br />
also concluded that the claims did not require the transformation of a<br />
specific article. The claims did not “require the transformation of the<br />
gray scale images into another image … [T]hese two patents merely<br />
recite the comparison as something ‘which is designed to produce …’<br />
dot profiles. The claim does not make this production or transformation<br />
a realized action through the patent process. Instead it recites it<br />
as a potential outcome of the comparison and does not require any<br />
visual depiction or subsequent display.” Id. at *38-39. 7<br />
In H&R Block Tax Services, Inc. v. Jackson-Hewitt Tax Service,<br />
Inc., Case No. 6:08-cv-00037, Docket No. 107 (E.D. Tex. Nov. 10,<br />
2009), the magistrate judge recently recommended that the court<br />
partially grant a motion for summary judgment of invalidity based on<br />
arguments that the patent claims at issue failed Bilski’s “machineor-transformation”<br />
test. Some of the claims at issue involved “computerized<br />
system” claims for providing a loan based on an anticipated<br />
tax refund, as well as a “computer-implemented method” for<br />
providing a loan to a taxpayer based on an anticipated tax refund. In<br />
some claims, the loan was provided on a “spending vehicle,” such as<br />
a prepaid credit card or similar device.<br />
Drawing inferences in the plaintiff’s favor for the purpose of summary<br />
judgment, the magistrate nevertheless found that the “computerized<br />
systems” claims were not patent-eligible under Section 101<br />
and thus invalid. In particular, the magistrate found that the claims<br />
directed to a “computerized system for distributing spending vehicles”<br />
involved assigning rights and financial relationships between<br />
entities, which he found was “simply an abstract intellectual<br />
concept” and, although they were not process claims as in Bilski,<br />
they ran afoul of the Supreme Court’s prohibition against claiming a<br />
fundamental principle. Id. at 10 & n.2. 8 In general, the magistrate<br />
found that, to the extent the computerized system claims recited a<br />
computer, it was “not a particular, special-purpose machine,” and<br />
thus was “an insignificant, extra-solution component of the claimed<br />
system” that failed to impose any meaningful limits on the claim or<br />
render an otherwise patent-ineligible claim eligible. Id. at 11, 12. 9<br />
The remaining claims at issue recited “a method utilizing an ‘electronic<br />
tax preparation system,’” which the plaintiff argued required<br />
the use of a computer. Id. at 13. The magistrate found that the computer<br />
was involved in three of the steps: (1) preparing a tax return;<br />
(2) obtaining tax return data; and (3) executing an agreement related<br />
to a spending vehicle. The magistrate found the computer’s use in<br />
the first two steps insufficient to make the claimed process patenteligible.<br />
On the other hand, the magistrate found that the third step<br />
of executing an agreement was an essential part of the claim (and<br />
( continued on page 14 )
( continued from page 13 )<br />
thus not insignificant extra-solution activity), and imposed meaningful<br />
limits on the claims since it does not preempt all methods<br />
of executing such agreements. Id. at 14. Based on this finding,<br />
the magistrate found the method claims to be sufficiently tied to a<br />
particular machine to pass Bilski’s “machine-or-transformation test”<br />
for patentable subject matter. Id. at 15.<br />
Other Post-Bilski Decisions<br />
While the Federal Circuit and a few district courts have issued opinions<br />
relying upon Bilski, the BPAI has been very active in applying<br />
the machine-or-transformation test. In particular, since Bilski was<br />
decided, the BPAI has issued almost 100 decisions purporting to<br />
apply the Federal Circuit’s test for patent eligibility. Some of the<br />
BPAI’s decisions are simple extensions of Bilski, rejecting claims<br />
that recite methods of organizing human or business activities.<br />
However, numerous BPAI decisions address claims that, prior<br />
to Bilski, were routinely approved as patent-eligible (e.g., claims<br />
reciting a computer-readable medium and/or a system containing<br />
a processor for executing a sequence of steps). A representative<br />
sampling of the BPAI’s decisions reveals that it is not business<br />
as usual at the PTO when it comes to applying the test for patent<br />
eligibility under Section 101.<br />
Methods for Identifying Information or Organizing Activities<br />
Have Been Rejected<br />
In line with the Federal Circuit’s statement that method steps<br />
manipulating legal obligations, legal relationships, business risks,<br />
human activities or other such abstractions cannot meet the patent<br />
eligibility test because such steps are not applied to physical objects<br />
or substances, the BPAI routinely has rejected claims that are not<br />
tied to a particular machine, merely organize human activities or<br />
merely gather information for identification purposes. For instance,<br />
in Ex parte Toth, No. 2008-4543, 2009 Pat. App. LEXIS 13 (BPAI<br />
June 15, 2009), the BPAI rejected claims under Section 101 that<br />
were directed to methods for “providing a one game scratch match<br />
play single elimination tournament for league players.” Id. at *1. The<br />
steps of the method included providing a pool of players, placing<br />
players into divisions and conducting various rounds of competition.<br />
The claims were rejected under Section 101 as they did not “limit<br />
the play to any particular game” and did “not limit the method to<br />
implementation using any particular machine or apparatus.” Id. at<br />
*5-6. The claims were analogized to the rejected claims in Bilski<br />
as the pending claims merely called for the performance of method<br />
steps “that involve transformations or manipulations of relationships.”<br />
Id. at *6.<br />
In a companion case decided the same day, Ex parte Toth, No.<br />
2009-9323, 2009 Pat. App. LEXIS 15 (BPAI June 15, 2009), the<br />
BPAI similarly rejected claims directed to “a one game scratch<br />
match play single elimination tournament for league players.” Id.<br />
at *1. Unlike the prior case, the claims involved in this appeal did<br />
identify a game (“setting a minimum number of games bowled”)<br />
and did recite some apparatus elements (e.g., bowling pins: “establishing<br />
multiple average divisions based on 10-pin or 15-pin average<br />
divisions;” television broadcasting: “each division champion<br />
bowling in separate television telecasts”). Despite these recitations,<br />
the BPAI held that the claims did not satisfy Section 101 as<br />
they were not “tied to a particular machine or apparatus.” Id. at<br />
*6. The BPAI held that the recitation of “pins” was not sufficient,<br />
nor carried throughout the claims so as to limit them to a particular<br />
apparatus, as “the competition could be conducted via a computer<br />
IP® EVIEW<br />
14<br />
in a virtual bowling tournament or in person with an actual bowling<br />
ball and pins.” Id. at *6-7. With regard to the television telecast<br />
reference, the BPAI held that references “in the claim to television<br />
telecasts do not impose any meaningful limits on the claimed<br />
method because the method is directed to tournament play to<br />
determine a champion and thus the display of the actual championship<br />
play on the television is merely ‘insignificant extra-solution<br />
activity.’” Id. at *7.<br />
With regard to methods for identifying information or organizing<br />
activities, the BPAI similarly has rejected the following types of<br />
claims: steps for implementing a best practice idea within an organization<br />
10 , steps for collecting payments from customers having<br />
delinquent accounts 11 , steps for selecting software and hardware<br />
based on business needs 12 , steps for preventing the processing of<br />
suspect trades 13 , steps for identifying relationships between users<br />
of a social networking site 14 , steps for establishing the reliability of<br />
a part based on data analysis 15 , steps for developing a solution to<br />
customer experience requirements 16 , steps for making healthcare<br />
patient credit decisions 17 , and steps for identifying trade secrets of<br />
a business. 18<br />
Recitation of a Computer Not Always Sufficient<br />
Since Bilski was decided, numerous claims reciting a general<br />
purpose computer or processor have been rejected as insufficiently<br />
tied to a particular machine. For instance, in Ex parte Gutta, No.<br />
2008-3000, 2009 Commr. Pat. LEXIS 59 (Jan. 15, 2009), new<br />
grounds for rejection under Section 101 were entered for several<br />
claims directed to a computerized method for recommending<br />
items to a target user. The claims at issue recited a computerized<br />
method “performed by a data processor” for recommending one or<br />
more items based in part on the selection history of a third party.<br />
Id. at *1. The method claims also recited a step of displaying a recommendation<br />
score to a target user. Id. at *2. The opinion noted<br />
that the recitation of these elements fell within the category of<br />
claims that Bilski did not address. 19 Nonetheless, the claims were<br />
rejected for not complying with the machine-or-transformation test.<br />
The inclusion of a “computerized method performed by a data<br />
processor” phrase in the claims was held to be insufficient under<br />
the first prong of the Bilski test in that the phrase added “nothing<br />
more than a general purpose computer that is associated with the<br />
steps of the process in an unspecified manner. Such a field-of-use<br />
limitation is insufficient to render an otherwise ineligible process<br />
claim patent eligible.” Id. at *6. Similarly, the step of “displaying”<br />
was not tied to any particular machine and could “be accomplished<br />
simply by writing the resulting score on a piece of paper.” Id. at<br />
*6-7. Finally, the opinion noted that the claims failed the transformation<br />
prong of the Bilski test because the data being manipulated<br />
did “not represent physical and tangible objects. Rather, the data<br />
represents information about user selection histories, an intangible.”<br />
Id. at *7.<br />
More recently, in Ex parte Myr, App. 2009-005949 (BPAI Sept.<br />
18, 2009), the BPAI rejected method claims directed “a computer<br />
implemented method for appraising real estate.” The BPAI<br />
held that steps of “storing” values constituted data gathering,<br />
“performing nonlinear programming” was a formula-manipulating<br />
step, and that “providing signals” was a post-solution activity. Id.<br />
at 12-14. Since the method did not transform a particular article<br />
into a different state or thing (appraising “does not transform the<br />
land in any physical way”), the BPAI analyzed whether “computerimplemented”<br />
in the preamble of the claim was sufficient to render<br />
( continued on page 15 )
( continued from page 14 )<br />
the claim patent-eligible as “tied to a particular machine.” “Given<br />
that claim 1 recites no other structure in the body of the claim, the<br />
phrase ‘computer-implemented’ in the preamble of claim 1 is a<br />
nominal recitation of structure.” Id. at 17. “To elevate such a token<br />
recitation of a computer to that of a ‘particular’ machine that would<br />
satisfy the machine prong of the Bilski machine-or-transformation<br />
test would be to permit clever drafting of process subject matter<br />
not contemplated by the case law and to exalt form over substance<br />
in determining whether the claimed process passes § 101 muster.”<br />
Id. at 18.<br />
In Ex parte Greene, App. No. 2008-4073 (BPAI April 24, 2009), the<br />
BPAI addressed claims directed to a “computer system for performing<br />
a fast Fourier transform” that included “one or more vector<br />
processors configured as” “a non-final stage calculating means”<br />
and “a final stage calculating means.” Id. at 2-3. While the BPAI<br />
found the claims to be “clearly” distinguishable from the process<br />
claims at issue in Bilski, the BPAI nonetheless held the claims to be<br />
patent-ineligible under Section 101. The BPAI considered the claims<br />
as “apparatus claims that implement a mathematical algorithm (i.e.,<br />
a Fast Fourier Transform).” Id. at 11. In rejecting the claims, the<br />
BPAI emphasized that the output results of the calculation were “not<br />
used for any practical purpose or inventive application.” Id. at 13.<br />
The BPAI also held that the claims were not limited to a particular<br />
type of computer system: “Indeed, Appellant’s Specification<br />
expressly discloses that ‘[t]he method can be embodied in software<br />
that can run on a variety of computers known in the art, including<br />
without limitation, personal computers, workstation computers, and<br />
supercomputers known in the art.’” Id. (emphasis in original). If<br />
these “conventional hardware elements” were removed from the<br />
claim, the BPAI noted that the claims would be nonstatutory as<br />
being directed to an abstract idea and/or a fundamental principal (a<br />
mathematical algorithm). Id. In short, the BPAI held that “merely<br />
adding a nominal recitation of conventional computer hardware in a<br />
claim otherwise directed to a pure mathematical algorithm is merely<br />
an exercise in claim drafting that cannot, by itself, render the claim<br />
statutory.” Id. at 14. 20<br />
In Ex parte Snyder, App. No. 2008-4598 (BPAI May 12, 2009), the<br />
BPAI affirmed the rejection of claims directed to transforming text<br />
documents to XML documents. Certain claims were written as a<br />
“text to XML transformer, comprising: a transformer program …<br />
and a processor for executing,” while other claims were written as<br />
a process for converting text to XML. The BPAI held that recitation<br />
of “a processor” only nominally connected the claimed transformer<br />
to a machine since the processor was only recited for the purpose<br />
of executing the transformer program. Id. at 22. The specification<br />
did not disclose any particular processor, but instead suggested<br />
that “any and every possible processor for performing the function”<br />
could be used. Id. In these circumstances, the BPAI held that the<br />
claimed transformer was not a machine. While the process claims<br />
did not recite a processor or computer, they did recite executing a<br />
program. Nonetheless, the BPAI held that the process claims were<br />
not tied to any particular machine. Id. at 23. In addition, the BPAI<br />
stated that the only “transformation” occurring in the claims was a<br />
transformation from one digital data form to another. Id. “Here, we<br />
do not have a transformation of physical subject matter but merely<br />
an abstract expression that is created from converting data from text<br />
to XML, which does not require any tangible output or result.” Id. at<br />
24 (emphasis in original). The BPAI held that this type of transformation<br />
did not satisfy the transformation prong of the machine-ortransformation<br />
test.<br />
IP® EVIEW<br />
15<br />
Software in a Computer-Readable Medium Not<br />
Always Patentable<br />
In addition to rejecting claims having a token recitation of a processor<br />
or general purpose computer, the BPAI has been active in rejecting<br />
otherwise ineligible process claims packaged as software stored<br />
on a computer-readable medium. For example, in Ex parte Cornea-<br />
Hasegan, 89 U.S.P.Q.2d (BNA) 1557 (BPAI 2009), the claims at issue<br />
concerned a method for predicting results of floating point mathematical<br />
operations and a computer-readable media including program<br />
instructions to perform the method. Although the method claims<br />
recited the use of a processor to perform the steps, the BPAI held<br />
that “the recitation of a processor does not limit the process steps<br />
to any specific machine or apparatus.” Id. at 1560. 21 The BPAI also<br />
held that the method claims did not transform an article or physical<br />
thing. “Rather, the data represents information about an abstract<br />
floating-point number, which is intangible.” Id. After addressing the<br />
method claims, the BPAI affirmed the rejection of claims directed to<br />
computer-readable media: “When broadly construed … the claimed<br />
‘computer-readable media’ limits the scope of the claimed media to<br />
tangible media embodiments such as the disclosed ‘fixed magnetic<br />
disk, [] floppy disk drive, [] optical disk drive, [] magneto-optical<br />
disk drive, [] magnetic tape, or non-volatile memory including flash<br />
memory.’ Even so, analysis of a ‘manufacture’ claim and a ‘process’<br />
claim is the same under Section 101.” Id. at 1561 (citations omitted).<br />
Thus, despite the recitation of tangible media, the BPAI concluded<br />
that the claim “is still directed to determining a result d from a<br />
mathematical algorithm. Additional recitations of computer- readable<br />
media, a hardware prediction unit, steps manipulating other<br />
data (floating-point operands) and determining whether to calculate<br />
d using floating point hardware are still insignificant extra-solution<br />
activities that fail to ‘transform an unpatentable principle into a<br />
patentable process.’ Limiting the claim to computer-readable media<br />
does not add any practical limitation to the scope of the claim.” Id. at<br />
1561 (citations omitted).<br />
Similarly, in Ex parte Mitchell, App. No. 2008-2012 (BPAI Feb. 23,<br />
2009), the BPAI affirmed the rejection of method, computer-readable<br />
medium, and system claims under Section 101. The claims were<br />
directed to “identifying co-evolving regions in the memory of a<br />
target application” so as to prevent computer memory space from<br />
being reclaimed for other uses in the computer. The BPAI rejected<br />
the method claims under the machine-or-transformation test as the<br />
claims were not tied to a particular machine and they did not recite<br />
an article that was transformed to a different state or thing. The<br />
computer-readable medium claim was rejected for the same reason:<br />
“We see no reason why a ‘computer-readable medium’ containing<br />
‘instructions’ for the otherwise ineligible method should be treated<br />
any differently from the non-statutory method recited in” the<br />
method claim. Id. at 8. The “system” claim was likewise rejected:<br />
“Limiting the claim to part of a system comprising a ‘processor’ and<br />
‘memory’ does not add any practical limitation to the scope of the<br />
claim. Similar to a field-of-use limitation in a process claim, the use<br />
of a general ‘processor’ and ‘memory’ is insufficient to render an<br />
otherwise ineligible claim patent eligible.” Id. at 11. 22<br />
In Ex parte Gutta, App. No. 2008-4366 (BPAI Aug. 10, 2009), the<br />
BPAI addressed three types of claims: (1) methods for identifying<br />
one or more mean items for a plurality of items, (2) systems for<br />
identifying one or more mean items including a memory and a<br />
processor configured to compute various values, and (3) an article<br />
of manufacture for identifying one or more mean items comprising<br />
a computer-readable medium having computer-readable program<br />
( continued on page 16 )
( continued from page 15 )<br />
code to perform various steps. The BPAI held that all three types<br />
of claims were not statutory under Section 101. With regard to<br />
the method claims, the BPAI held that they were not tied to any<br />
particular machine and they did not transform an item into a different<br />
state or thing. However, when addressing the system and article of<br />
manufacture claims, the BPAI applied a modified version of the Bilski<br />
test to determine patent eligibility. In particular, the BPAI noted that<br />
a machine or article of manufacture that involves a mathematical<br />
algorithm is not patent-eligible if it fails one of these two tests: “(1)<br />
Is the claim limited to a tangible practical application, in which the<br />
mathematical algorithm is applied, that results in a real-world use<br />
(e.g., ‘not a mere field-of-use label having no significance’)? (2) Is<br />
the claim limited so as to not encompass substantially all practical<br />
applications of the mathematical algorithm either ‘in all fields’ of use<br />
of the algorithm or even in ‘only one field?’” Ex parte Gutta, App.<br />
No. 2008-4366 at 15. 23 Applying these tests, the BPAI held that<br />
the system and computer-readable medium claims were not patenteligible<br />
because they encompassed all practical applications of the<br />
mathematical algorithm and thus claimed “the algorithm itself.” Id.<br />
at 22.<br />
Computer Simulations May Not Pass Muster Under<br />
Section 101<br />
In a recent decision, the BPAI applied Section 101 to reject claims<br />
directed to methods for rendering “a volumetric obscurant” (e.g.,<br />
a simulated cloud) “in a computer generated graphical image” by<br />
executing an algorithm defining a polygon region having pixels,<br />
spreading the pixels, and modulating a density of the pixels “to<br />
create a realistic image of a volumetric obscurant.” In Ex parte<br />
Gardiner, App. No. 2009-001597 (BPAI Oct. 22, 2009), the BPAI<br />
rejected the pending claims as not being tied to a particular machine.<br />
The BPAI noted that “the claimed method is directed to applying<br />
the algorithm to an image and is therefore not tied to a particular<br />
machine.” Id. at 5. The BPAI also held that transforming a computer<br />
image into another image containing a cloud (as would be accomplished<br />
in simulating the visual effect of an airplane flying through<br />
a cloud) does not transform an article into a different state or thing<br />
under the machine-or-transformation test: “neither the polygon nor<br />
the obscurant represents a physical item; rather, the polygon is an<br />
abstraction to define a region of an image. The obscurant is also<br />
an abstraction as it is not based upon a physical item, but rather is<br />
part of a simulation … Thus [] the steps … recited in claim 1 do not<br />
transform any physical object.” Id. at 6. 24<br />
Argument Before the Supreme Court<br />
On November 9, 2009, the Supreme Court heard oral arguments in<br />
the appeal of the Federal Circuit’s en banc Bilski opinion. Although it<br />
was unclear from the oral argument how the Court might rule, it was<br />
clear that the Justices recognized the importance of this case and<br />
the potential far-reaching effects of any decision they may render,<br />
noting in particular the “80 briefs” filed in the case. Bilski v. Kappos,<br />
Case No. 08-964, Official Transcript, 32:1-4 (Sup. Ct. Nov. 9, 2009).<br />
A majority of the Justices appeared to have some level of discomfort<br />
with the claims in Bilski’s patent and, thus, it seems unlikely that the<br />
Court will find Bilski’s patent claims to be patent-eligible. Several<br />
of the Justices noted that the Bilski patent application was directed<br />
to the types of processes for which patents were not sought years<br />
ago—suggesting that these types of claims were not patent-eligible.<br />
Chief Justice Roberts and Justice Kennedy noted that risk hedging<br />
has been common in the insurance industry for years without the<br />
protection of patents. Justice Sotomayor expressed doubts about<br />
IP® EVIEW<br />
16<br />
the benefit of patents like Bilski’s that only require human activities,<br />
without requiring any technology, asking “why not patent a method<br />
of speed dating?” Id. at 7:7-12. The Justices gave other examples of<br />
the types of protection that they thought would be similarly ineligible<br />
for patent protection: buying low and selling high to maximize<br />
wealth, attempting to patent a horse training technique, attempting<br />
to patent a technique of writing a book on how to win friends and<br />
influence people, attempting to patent a method for teaching antitrust<br />
law, and speed-dating.<br />
Bilski’s counsel argued that the claims are valid, not under the<br />
machine-or-transformation test, rather because they involved<br />
physical steps. Upon making that argument, he was interrupted by<br />
the Chief Justice asking:<br />
CHIEF JUSTICE ROBERTS: I’m sorry. Just what are<br />
the physical steps? Initiating a series of transactions<br />
between commodity provider and market participants?<br />
MR. JAKES: That would be one.<br />
CHIEF JUSTICE ROBERTS: You get on the phone and<br />
you call the baker and you get on the phone and you call<br />
the grocer and say: I can set up a deal for both of you?<br />
Id. at 11:19-12:2. Chief Justice Roberts later emphasized this same<br />
point on rebuttal, hinting at his dissatisfaction at a patent claim<br />
covering people conducting a transaction by phone.<br />
With regard to the test for patent eligibility, the Justices seemed<br />
concerned with the outer bounds of the Federal Circuit’s machineor-transformation<br />
test, noting that it leaves “much unresolved,”<br />
such as what the terms “machine” and “transformation” actually<br />
mean and how broad or narrow they are. Id. at 32. In addition, there<br />
was concern about the quality of the machine or the transformation<br />
with respect to the invention being claimed. Chief Justice Roberts<br />
was concerned that “the most tangential and insignificant use of a<br />
machine” might be able to transform something otherwise unpatetentable<br />
into something patentable. Id. at 33:3-7.<br />
It is far from certain how the Justices will articulate the test to<br />
govern patent eligibility under Section 101. One possibility is that<br />
they affirm the Federal Circuit’s machine-or-transformation test as<br />
there appears to be a general consensus that Bilski’s pending claims<br />
should not be patent-eligible. However, there is the possibility that<br />
they may make a narrow ruling. The government attorney noted<br />
explicitly that this case may not be the best vehicle for determining<br />
the bounds of patent-eligible subject matter in subject areas like<br />
software and medical diagnostics. Id. at 36:10-22. Indeed, the<br />
Court has waded into this murky water before, only to express its<br />
displeasure at the state of the law on patent-eligible subject matter<br />
without making any decision. 25<br />
Conclusion<br />
Although uncertainty exists as to what test the Supreme Court will<br />
articulate to judge questions of patent eligibility, it is clear that the<br />
Federal Circuit, district courts, BPAI and PTO have embraced Bilski’s<br />
machine-or-transformation test and are willing to invalidate and/or<br />
reject claims that do not meet the test. To prepare for the possibility<br />
that the Supreme Court will affirm this test for patent eligibility, patentees<br />
and patent applicants should conduct a serious review of their<br />
pending applications and existing United States patent portfolios to<br />
( continued on page 17 )
( continued from page 16 )<br />
make sure that their claims will pass the machine-or-transformation<br />
test. While changes to claims in pending applications can be made<br />
through simple amendments, revising claims through reissue is<br />
not as simple. Moreover, as the average prosecution pendency<br />
of reissue applications is approaching five years, patentees should<br />
review their portfolios during the pendency of the Bilski appeal so<br />
that they are ready to pursue reissue applications, if necessary,<br />
shortly after the Supreme Court renders its decision.<br />
In terms of strategic considerations for litigation, amendments to<br />
pleadings should be made where necessary to assert arguments<br />
that are available under the Bilski line of decisions. Similarly, where<br />
claims of any patents-in-suit appear to fail the Federal Circuit’s<br />
machine-or-transformation step, it may make sense to consider<br />
summary judgment motions based on Bilski and its progeny.<br />
Additionally, licenses and/or settlement agreements that involve<br />
patents that are on shaky ground under Bilski should be reviewed.<br />
As with preparations of reissue applications, it makes sense to begin<br />
reviewing these documents during the pendency of the Bilski appeal<br />
to be ready to approach the other parties once the Supreme Court<br />
renders its decision. �<br />
1 This test, derived from a series of cases, namely In re Freeman, 573 F.2d 1237 (CCPA<br />
1978), In re Walter, 618 F.2d 758 (CCPA 1980), and In re Abele, 684 F.2d 902 (CCPA<br />
1982), involved two steps: (1) determining if the claim recited an algorithm and (2)<br />
determining whether the algorithm was applied in any manner to physical elements<br />
or process steps.<br />
2 The “useful, concrete and tangible result” test arose from several cases, namely<br />
AT&T Corp. v. Excel Commc’ns, Inc., 172 F.3d 1352 (Fed. Cir. 1999), State St. Bank &<br />
Trust Co. v. Signature Fin. Group, 149 F.3d 1368 (Fed. Cir. 1998), and In re Alappat, 33<br />
F.3d 1526 (Fed. Cir. 1994).<br />
3 The applicants in Ferguson proposed that the Federal Circuit consider a new test:<br />
“Does the claimed subject matter require that the product or process has more<br />
than a scintilla of interaction with the real world in a specific way?” In re Ferguson,<br />
558 F.3d at 1364. The Federal Circuit rejected that proposal and reaffirmed the<br />
machine-or-transformation test as the sole test for a process claim under Section<br />
101. Id. Like the applicants in Ferguson, amici filing briefs with the Supreme<br />
Court have proposed various different tests for patent eligibility. See, e.g., Brief<br />
for Bank of America et al. (processes are patent-eligible only when physically<br />
transformative or tied to the nonconventional use of a particular machine); Brief for<br />
Microsoft Corporation et al. (processes are patent-eligible when they describe a<br />
series of steps that use physical means to produce a result or effect in the physical<br />
world); Brief for Dolby Labs. et al. (processes that apply scientific/technological<br />
principles to achieve a result that has practical application are patent-eligible); Brief<br />
of Regulatory Datacorp, Inc. et al. (ordinary, broad meaning of process should<br />
be adopted in view of normal statutory construction principles); Brief of Yahoo!<br />
Inc. (patent eligibility predicated upon whether the claimed process sets forth<br />
a series of clearly defined steps that are stable, predictable, and reproducible);<br />
Brief for Bilski (practical application of a principle in an art or process is the test for<br />
patent eligibility); Brief for IBM (patent eligibility depends upon whether a process<br />
provides a technological contribution without preempting the use of laws of nature,<br />
natural phenomena, mental processes, or abstract ideas); Brief for 20 Law and<br />
Business Professors (applied ideas are eligible for patenting, whereas ideas in the<br />
abstract are not).<br />
4 The Federal Circuit’s decision in Prometheus Labs. likely will be applied to a<br />
matter currently on appeal to the Federal Circuit. In King Pharmaceuticals, Inc.<br />
v. Eon Labs, Inc., 593 F. Supp. 2d 501 (E.D.N.Y. 2009), the district court granted<br />
summary judgment that a dependent claim was invalid under Section 101 because<br />
it only recited the step of informing another person of the effect of administering<br />
a particular drug with or without food. The court held that the “act of informing<br />
another person of the food effect of metaxalone does not transform the<br />
metaxalone into a different state or thing.” King Pharmaceuticals, 593 F. Supp. 2d<br />
at 512-13. However, in light of the Federal Circuit’s determination in Prometheus<br />
Labs. that administering drugs is “always transformative,” it is unlikely that the<br />
court’s decision in King Pharmaceuticals will stand since the independent claim<br />
recites the positive step of “administering to the patient a therapeutically effective<br />
amount of metaxalone”. Id. at 506.<br />
5 A similar conclusion was reached in Ex parte Roberts, App. No. 2009-009323 (BPAI<br />
June 19, 2009), wherein the BPAI rejected a claim directed to a method for creating a<br />
real estate investment instrument adapted for performing tax-deferred exchanges.<br />
IP® EVIEW<br />
17<br />
6 In making this determination, the court did not squarely address the language of<br />
Section 100(b) that a “process” “includes a new use of a known … machine.” It is<br />
not clear that any court has squarely addressed the argument of whether software<br />
operating on a computer or processor constitutes a new use (e.g., enumerated<br />
software routines) of a known machine (e.g., a general purpose computer).<br />
7 In contrast to the two patents that were invalidated, the court confirmed the<br />
patentability of three patents under Section 101. These patents also had claims<br />
directed to methods of “halftoning.” However, unlike the other two patents, these<br />
patents had limitations requiring the production of a “halftoned image.” While the<br />
court concluded that the claims in the three patents did not meet the first prong<br />
of the Bilski test (tied to a particular machine), the court held that they did satisfy<br />
the second prong (transformation). In particular, the halftoned images “are the<br />
manifestation of a particular transformation. The patent dictates a transformation of<br />
specific data, and is further limited to a visual depiction which represents specific<br />
objects.” Research Corp. Technologies, Inc. v. Microsoft Corp., 2009 U.S. Dist. LEXIS<br />
71883 at *45.<br />
8 Specifically, the magistrate cited Funk Bros. Seed Co. v. Kalo Co., 333 U.S. 127<br />
(1948), as holding invalid a product claim for preempting a fundamental principle,<br />
and Gottschalk v. Benson, 409 U.S. 63 (1972), as holding invalid a process claim for<br />
preempting a fundamental principle.<br />
9 The magistrate analogized the “extra-solution component” of the computerized<br />
system claims to the “extra-solution step” that the Federal Circuit held in Bilski would<br />
be insufficient to render otherwise unpatentable process claims patent-eligible.<br />
10 Ex parte Sandoval, App. No. 2009-000175 (BPAI Sept. 25, 2009).<br />
11 Ex parte Haworth, App. 2009-000350 (BPAI July 30, 2009).<br />
12 Ex parte Hemmat, App. No. 2009-003911 (BPAI Oct. 13, 2009).<br />
13 Ex parte Delta, App. No. 2009-000982 (BPAI May 26, 2009).<br />
14 Ex parte Dom, App. No. 2008-002470 (BPAI May 29, 2009).<br />
15 Ex parte Babu, App. No. 2008-4851 (BPAI May 29, 2009).<br />
16 Ex parte Farnes, App. No. 2009-002770 (BPAI June 2, 2009).<br />
17 Ex parte Johnson, App. No. 2009-000714 (BPAI June 8, 2009).<br />
18 Ex parte Halligan, 89 U.S.P.Q.2d (BNA) 1355 (BPAI 2008).<br />
19 In rendering its decision in Bilski, the Federal Circuit noted that it would “leave to<br />
future cases the elaboration of the precise contours of machine implementation, as<br />
well as the answers to particular questions, such as whether or when recitation of<br />
a computer suffices to tie a process claim to a particular machine.” Bilski, 545 F.3d<br />
at 962.<br />
20 See also Ex parte Holtz, App. No. 2008-004440 (BPAI Aug. 24, 2009); Ex parte Goud,<br />
App. No. 2008-003121 (BPAI July 20, 2009); Ex parte Dang, App. No. 2009-000984<br />
(BPAI June 29, 2009); Ex parte Caputo, App. No. 2008-004868 (BPAI June 18, 2009)<br />
(an “unspecified ‘processing’ or ‘computing’ device performing the claims algorithm<br />
is not sufficient … to tie the claimed process to a ‘particular’ machine or apparatus”);<br />
Ex parte Avinash, App. No. 2009-1542 at 22 (BPAI June 2, 2009) (“a general purpose<br />
computing system does not tie claim 10 to a special purpose or particular machine”);<br />
Ex parte Nawathe, App. No. 2007-3360 (BPAI Feb. 9, 2009).<br />
21 With regard to the “processor” limitation, the BPAI also commented as follows:<br />
“The recitation of a ‘processor’ performing various functions is nothing more than a<br />
general purpose computer that has been programmed in an unspecified manner to<br />
implement the functional steps recited in the claims. The recitation of a processor in<br />
combination with purely functional recitations of method steps, where the functions<br />
are implemented using an unspecified algorithm, is insufficient to transform<br />
otherwise unpatentable method steps into a patent eligible process.” Ex parte<br />
Cornea-Hasegan, 89 U.S.P.Q.2d (BNA) at 1560-61.<br />
22 See also Ex parte Busche, App. No. 2008-004750 (BPAI May 28, 2009) (rejecting<br />
claims directed to a “computer program product in a computer-readable medium<br />
comprising instructions for enabling a data processing machine to select data<br />
sets”); Ex parte Mau, App. No. 2009-0065 (BPAI May 1, 2009) (“merely reciting<br />
data or instructions on a stored computer-readable medium does not make a<br />
claim patentable”).<br />
23 See also Ex parte Market, App. No. 2009-001843 at 6 (BPAI Oct. 23, 2009) (same); Ex<br />
parte Forman, App. No. 2008-005348 at 16 (BPAI Aug. 17, 2009) (same).<br />
24 See also Ex parte Petculescu, App. No. 2008-002859 (BPAI June 4, 2009) (purported<br />
transformation of data about an intangible, abstract dimensional model is not patenteligible).<br />
25 See LabCorp. v. Metabolite Labs., Inc., 548 U.S. 124 (2006) (writ of certiorari on case<br />
involving diagnostic test dismissed as improvidently granted on a 5-3 vote; Justices<br />
Breyer, Stevens and Souter dissenting that the subject patent claim was directed to a<br />
natural process and unpatentable).
<strong>Skadden</strong> Contacts<br />
New York Office<br />
4 Times Square | New York, NY 10036<br />
Daniel A. DeVito | Partner<br />
212.735.3210 | Daniel.DeVito@skadden.com<br />
Anthony J. Dreyer | Partner<br />
212.735.3097 | Anthony.Dreyer@skadden.com<br />
Jose A. Esteves | Partner<br />
212.735.2948 | Jose.Esteves@skadden.com<br />
Edward V. Filardi | Partner<br />
212.735.3060 | Edward.Filardi@skadden.com<br />
Bruce J. Goldner | Partner<br />
212.735.2972 | Bruce.Goldner@skadden.com<br />
Stuart D. Levi | Partner<br />
212.735.2750 | Stuart.Levi@skadden.com<br />
Douglas R. Nemec | Partner<br />
212.735.2419 | Douglas.Nemec@skadden.com<br />
Kenneth A. Plevan | Partner<br />
212.735.3410 | Kenneth.Plevan@skadden.com<br />
Rita Rodin Johnston | Partner<br />
212.735.3774 | Rita.Rodin@skadden.com<br />
David W. Sussman | Of Counsel<br />
212.735.2686 | David.Sussman@skadden.com<br />
Jessica N. Cohen | Counsel<br />
212.735.2793 | Jessica.Cohen@skadden.com<br />
Mary E. Rasenberger | Counsel<br />
212.735.3565 | Mary.Rasenberger@skadden.com<br />
P. Anthony Sammi | Counsel<br />
212.735.2307 | Anthony.Sammi@skadden.com<br />
IP® EVIEW<br />
18<br />
James S. Talbot | Counsel<br />
212.735.4133 | James.Talbot@skadden.com<br />
Elaine D. Ziff | Counsel<br />
212.735.2656 | Elaine.Ziff@skadden.com<br />
Matthew B. Zisk | Counsel<br />
212.735.3056 | Matthew.Zisk@skadden.com<br />
Palo Alto Office<br />
525 University Ave. | Suite 1100 | Palo Alto, CA 94301<br />
Chuck Ebertin | Partner<br />
650.470.4550 | Chuck.Ebertin@skadden.com<br />
David W. Hansen | Partner<br />
650.470.4560 | David.Hansen@skadden.com<br />
Bernard Shek | Counsel<br />
650.470.4513 | Bernard.Shek@skadden.com<br />
Washington, D.C. Office<br />
1440 New York Avenue, N.W. | Washington, D.C. 20005<br />
Cliff Sloan | Partner<br />
202.371.7040 | Cliff.Sloan@skadden.com<br />
Boston Office<br />
One Beacon Street | Boston, MA 02108<br />
Scott Brown | Counsel<br />
617.573.4874 | Scott.Brown@skadden.com<br />
Justin J. Daniels | Counsel<br />
617.573.4826 | Justin.Daniels@skadden.com